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Abstract 
Antimicrobial resistance has become a major public health threat and is particularly a problem in 
low- to middle-income countries (LMICs) where there is a high burden of infectious diseases. The 
implementation of an antimicrobial stewardship programme (AMS) is essential to reduce the 
development of resistance. However, adequate resources are often a problem, hence the 
necessity to investigate the availability of alternative, more cost-effective solutions. Including 
nurses in antimicrobial stewardship teams can add value due to the fact that nurses are in an ideal 
position to monitor the duration of antimicrobial treatment. Furthermore, nurses are responsible for 
the administration of medication and the collection of appropriate specimens and are primarily 
responsible for the care of the patient.  
The objectives of this study were to examine the role of the critical care nurse in the 
implementation of an antimicrobial stewardship programme in LMICs and to identify interventions 
where the critical care nurse plays a significant role as part of the AMS team.  
A pre- and post-intervention interventional study design was followed where various interventions 
were implemented to establish which of these interventions can be implemented successfully by 
nurses with a meaningful impact on an AMS programme.  
The study found that nurses can play an important role in the implementation of an AMS 
programme and that they are a cost-efficient resource. Nurses should be an essential part of an 
AMS team. Additional training about AMS and infection prevention and control (IPC) is necessary 
and the training should be directed at the team; including nurses, doctors and pharmacists. 
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Opsomming 
Antimikrobiese weerstandigheid is ’n wesentlike bedreiging vir publieke gesondheidsorg en dit is 
veral ’n probleem in lae- tot middel-inkomste lande waar daar ’n groot las is van aansteeklike 
siektes. Die implementering van ’n antimikrobiese bewusmakingsprogram is belangrik om die 
ontwikkeling van weerstandigheid te verminder. Voldoende hulpbronne is egter dikwels ’n 
probleem en gevolglik moet ander beskikbare en koste-effektiewe bronne ondersoek word. Die 
insluiting van verpleegkundiges in antimikrobiese bewusmakingspanne kan moontlik waarde 
toevoeg as gevolg van die feit dat verpleegkundiges in ’n gunstige posisie is om die duur van 
behandeling met ‘n antibiotikum te monitor. Verder is verpleegkundiges ook verantwoordelik vir die 
toediening van medikasie en die verkryging van toepaslike laboratorium-monsters en is hulle 
primêr verantwoordelik vir die versorging van die pasiënt.  
Die doel van die studie was om die rol van die kritieke-sorg verpleegkundige te ondersoek in die 
implementering van ’n antimikrobiese moniteringsprogram in lae- tot middel-inkomste lande en om 
verder te bepaal watter intervensies geïmplementeer kan word sodat die kritieke-sorg 
verpleegkundige ’n betekenisvolle rol kan speel in die implementering van ’n antimikrobiese 
moniteringsprogram.   
Die studie-ontwerp was ‘n voor- en na-intervensie studie.  Verskeie intervensies is geïmplementeer 
om te bepaal watter intervensies suksesvol deur verpleegkundiges geïmplementeer kan word om 
’n beduidende invloed op ’n antimikrobiese moniteringsprogram te hê.  
Die bevindinge van die studie was dat verpleegkundiges ’n belangrike rol kan speel in die 
implementering van antimikrobiese moniteringsprogramme en dat hulle ’n koste-effektiewe 
hulpbron is. Verpleegkundiges behoort deel te wees van ’n antimikrobiese span. Opleiding in 
antimikrobiese moniteringsprogramme en infeksievoorkoming en -beheer is egter nodig en moet 
gerig wees op die hele span, insluitende geneeshere, verpleegkundiges en aptekers.  
Sleutelwoorde: 
antimikrobiese moniteringsprogram 
infeksievoorkoming en -beheer 
kritiese-sorg verpleegkundige 
lande met beperkte hulpbronne 
Suid-Afrika 
intervensies 
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Glossary 
Antibiotic 
Any class of organic molecule that inhibits or kills microbes by specific interactions with bacterial 
targets, without any consideration of the source of the particular compound of class (Davies & 
Davies, 2010:417) 
Antimicrobial 
A general term referring to a group of drugs, that includes antibiotics, antifungals, antiprotozoal 
drugs and antivirals that inhibits the growth of pathogenic micro-organisms (MedicineNet, 2015a; 
Merriam-Webster, 2015). 
Antimicrobial stewardship 
This refers to “coordinated interventions designed to improve and measure the appropriate use of 
antimicrobials by promoting the selection of the optimal antimicrobial drug regimen, dose, duration 
of therapy, and route of administration. Antimicrobial stewardship seeks to achieve optimal clinical 
outcomes related to antimicrobial use, minimize toxicity and other adverse events, reduce the cost 
of healthcare for infections and limit the selection for antimicrobial resistant strains”  (Infectious 
Diseases Society of America (IDSA), 2000).  
Care bundle 
A care bundle is a structured way of improving processed of care and patient outcomes through a 
set of evidence-based interventions. It has proof that these interventions improve patient outcomes 
if implemented collectively every time (Institute of Healthcare Improvement, 2012).  
Clinical pharmacist 
A clinical pharmacist is a licensed specialist pharmacist working in an area of pharmacy involved 
with the science, practice, activity and service to develop and promote the rational and appropriate 
use of medicines, in the best interest of patients and the community (South African Society of 
Clinical Pharmacy, 2015). 
Critical care nurse  
A critical care nurse is a registered nurse with specialist training and knowledge of the critically ill 
and unstable patient and the skill and competency to function within a complex technological 
environment (South African Nursing Council, 2014).  
De-escalation 
The provision of effective initial antimicrobial treatment, while avoiding unnecessary antimicrobial 
use that would promote the development of resistance (Masterton, 2011:150). 
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Empiric antibiotic  
Empiric antibiotics are normally broad-spectrum and are used for the treatment of both Gram-
positive and Gram-negative bacteria. When more information is known (as from a blood culture), 
treatment may be changed to a narrow-spectrum antibiotic which more specifically targets the 
bacterium known to be causing disease or infection (Wikipedia, 2015a).  
Hang time 
Hang time refers to the time interval between prescription of an antibiotic and administration to the 
patient (South African Antibiotic Stewardship Programme, 2012).  
Infectious diseases specialist 
A physician or paediatrician with an additional specialised qualification in the management and 
treatment of infectious diseases and specialised knowledge of antimicrobials. (College of Medicine 
of South Africa, 2009).  
Resource-limited countries 
Any country that has a limitation in resources, such as available land, labour and capital. 
(Wikipedia, 2015b). 
Low-middle income country (LMIC)  
As of 1 July 2014, low-income economies are defined as those with a gross national income (GNI) 
per capita of $1 045 or less in 2013; middle-income economies are those with a GNI per capita of 
more than $1 045 but less than $12 746. 
Lower-middle-income and upper-middle-income economies are separated at a GNI per capita of 
$4 125. South African is classified by the World Bank as a low middle-income country (World Bank, 
2015a; World Bank, 2015b). 
The term ‘LMICs’ replaces the term ‘resource-limited countries’ in the rest of the document. 
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CHAPTER 1 
FOUNDATION OF THE STUDY 
1.1 INTRODUCTION 
Antimicrobials are effective in the treatment of infections, but inappropriate and unregulated use 
thereof has led to the development of resistance against most available antimicrobials; 
furthermore, aggravated by the emergence of untreatable strains such as carbapenem resistant 
enterobacteriaceae (Hurford, Morris, Fisman & Wu, 2012:203; Paruk, Richards, Scribante, 
Bhagwanjee, Mer, Perrie, 2012:613; Laxminarayan, Duse, Wattal, Zaidi, Wertheim et al., 
2013:1057). Inappropriate use of antimicrobials is not the only reason for antimicrobial resistance. 
Antibiotic resistance is a natural phenomenon. The natural evolution of living organisms to develop 
tolerance and resistance to therapeutic agents in itself is a major contributing factor to antimicrobial 
resistance (Davies & Davies, 2010:417).  Resistant strains, capable of inactivating a drug will 
appear as soon as an antibiotic is used widely. Over time, these micro-organisms will develop 
resistance to more and more therapeutic agents (Davies & Davies, 2010: 419). 
Antimicrobial resistance has become a major public health threat and is particularly a problem in 
low- to middle-income countries (LMICs) where there is a high burden of infectious diseases 
(Okeke, Laxminarayan, Bhutta, Duse, Jenkins et al., 2005a:481; Sahoo, Tamhankar, Johansson & 
Lundborg, 2010:1; Mendelson & Matsoso, 2015:325). A situational analysis of available information 
related to antimicrobial resistance and the rapid implementation of a national antimicrobials 
stewardship (AMS) programme has become necessary (Suleman & Meyer, 2012:14; Nathwani, 
Sneddon, Malcolm, Wiuff, Patton et al., 2011:17).   
The implementation of an antimicrobial stewardship (AMS) programme  to monitor antimicrobial 
usage and the prescribing habits of healthcare providers is essential to reduce the development of 
resistance (Dellit, Owens, McGowan, Gerding & Weinstein et al., 2007:159). Recommended 
strategies are complicated and problematic to implement in LMICs. Evidence related to the 
successful and sustained implementation of AMS programmes in these countries is limited (Okeke, 
Klugman, Bhutta, Duse, Jenkins et al., 2005b:568; Dellit et al., 2007: 159).  Clinical teams, 
comprising of a clinical pharmacist and infectious diseases specialist, are uncommon. Rural 
hospitals do not have access to these teams and clinical microbiologists and laboratory support are 
often lacking or inadequate. 
Where resources are lacking, Abbo, Smith, Pereyra, Wyckoff and Hooton (2012:376) found that 
the inclusion of nurse practitioners in AMS programmes may improve the effective use of 
antimicrobials. Nurses are in an ideal position to monitor and audit prescriptions due to the nature 
of their work; however, their role in the multidisciplinary team is not clear (Edwards, Drumright, 
Kiernan & Holmes, 2011:6). 
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1.2 BACKGROUND AND RATIONALE 
Paruk et al. (2012:613) stated that “the emergence of pan-resistant pathogens and the 
inappropriate use of antimicrobials is a global catastrophe receiving increasing attention from 
healthcare authorities”. In addition to the natural development of resistance of micro-organisms to 
antimicrobials over time, other factors that contribute to the development and spread of resistant 
pathogens are poor socio-economic status, high burden of infectious diseases, misuse of 
antimicrobials, the publics’ lack of knowledge and poor quality of antimicrobials available (Sahoo 
et al., 2010:1; Al-Tawfiq, Stephens & Memish, 2010:767; Okeke, Lamikanra & Edelman, 1999:24; 
Radyowijati & Haak, 2003:733-734, Davies & Davies, 2010:419).  Human behaviour has a 
significant impact on antimicrobial misuse and contributes to the development of resistance; 
impacting on societies worldwide (Laxminarayan et al., 2013: 1057).  
The lack of an effective infection prevention and control (IPC) programme contributes to the spread 
of antimicrobial resistant pathogens as there is very little evidence available on successful and 
sustainable interventions that have been implemented in LMICs (Okeke et al., 2005a:481; Okeke 
et al., 2005b:568).  Many interventions focus on education, but these programmes have not been 
evaluated to measure their sustainable effectiveness or determine whether the prescribing 
behaviour of healthcare workers has been positively affected (Okeke, Aboderin, Byarugaba, Ojo & 
Opintan, 2007:1644; Yam, Fales, Jemison, Gillum & Bernstein, 2012:1148). Studies in the United 
States of America confirmed that in rural communities, the appointment of clinical pharmacists, 
together with weekly consultations with infectious diseases specialists demonstrated a significant 
reduction in inappropriate antimicrobial usage (Yam et al., 2012:1142; Storey, Pate, Nguyen & 
Chang, 2012:2).  LMICs do not necessarily have clinical pharmacists and infectious disease 
physicians and need to explore alternative sustainable methods of monitoring antimicrobial usage 
and ways to change behaviour of healthcare workers.  
A multi-interventional approach is required comprising of the implementation of an AMS 
programme, together with protocol-specific empiric and therapeutic antimicrobials for the treatment 
of healthcare-associated infections (HAIs) and surgical prophylaxis (Dortch, Dossett, Fleming, 
Kauffmann, May & Talbot, 2011:15; Dellit et al., 2007:159-160).  Toth, Chambers and Davis 
(2010:746) and Coll, Kinnear and Kinnear (2012: 845) found that implementing a care bundle for 
antimicrobial stewardship increased appropriate de-escalation and improved adherence to 
evidence-based quality indicators, improving antimicrobial utilisation (Toth et al., 2010: 746; Coll 
et al., 2012: 845).   
The implementation of simple interventions leads to a substantive cost saving on the use of 
antimicrobials and is therefore feasible in LMICs (Goff, Bauer, Reed, Stevenson, Taylor & West, 
2012:587). Interventions such as stringent infection prevention and control (IPC) practices, 
surveillance, hand hygiene, monitoring of isolation precautions and antimicrobial stewardship is 
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required (Mendelson, Whitelay, Nicol & Brink, 2012:607; Chalfine, Kitzis, Bezie, Benali, Perniceni 
et al., 2012:1).  
A multi-disciplinary approach is required, which includes a clinical pharmacist, physician, infectious 
diseases specialist, microbiologist and an IPC practitioner (Dellit et al., 2007:165; Tamma & 
Cosgrove, 2011:245).  The involvement of a registered nurse has often been limited in these 
programmes (Edwards, Drumright et al., 2011:6). Abbo and colleagues (2012:373) found that the 
role of the critical care nurse in the antimicrobial stewardship team should not be underestimated 
and should be explored further. Nurses provide the most consistent patient care and have 
specialised knowledge about their patients. They conduct daily chart reviews, monitor patients and 
alert the treating physician should there be a change in a treatment protocol, based on certain 
infectious markers or laboratory results (Edwards, Drumright et al., 2011:9). Furthermore, critical 
care nurses can play a significant role in ensuring that appropriate specimens are collected prior to 
administration of an antimicrobial, antimicrobials are administered on time, at the correct dose and 
for the correct duration. Finally, nurses can advocate on behalf of the patient by reminding the 
physician of the number of antimicrobials with which the patient is treated and can question the 
appropriateness of such treatment. 
Weiss, DiBardino, Rho, Sung, Collander and Wunderink (2013:1) reported that face-to-face 
prompting of prescribing physicians, using a written checklist, led to an almost four-fold reduction in 
the prescribing of empiric antimicrobials. Checklists with evidence-based procedures have proven 
to be a successful intervention to improve quality of care and are valuable tools in reducing errors 
of omission; improving outcomes in critical ill patients (Weiss et al., 2013:1; Pronovost, Needham, 
Berenholtz, Sinopoli, Chu et al., 2006:2731). Nurses utilising checklists might be a simple, cost-
effective intervention that can have a positive effect on the implementation of an antimicrobial 
stewardship programme. 
In order for nurses to play a significant role in the implementation of an AMS programme, it is 
necessary to improve their knowledge about pharmacology, clinical evaluation, IPC and quality 
improvement methodology.    
Nurses can potentially be a cost-efficient resource that plays an important role in the 
implementation of an AMS programme, but their role needs to be defined (Edwards, Drumright 
et al., 2011:9). The role of critical care nurses has not been evaluated in the implementation of an 
AMS programme.  
1.3 RESEARCH QUESTION 
What is the role of the critical care nurse in the successful implementation of an antimicrobial 
stewardship programme in a low-middle income country?  
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1.4 PROBLEM STATEMENT 
The complexities associated with the implementation of AMS programmes, together with 
inadequate resources and lack of trained healthcare workers, are major limitations for the 
implementation of an AMS programme in low- to middle-income countries (LMICs).   
The role of the critical care nurse has not previously been defined in the implementation of an AMS 
programme and should be explored and evaluated further.   
1.5 HYPOTHESIS  
The null hypothesis states that the critical care nurse does not play a role in the implementation of 
an antimicrobial stewardship programme.  
1.6 RESEARCH GOALS 
The goal of the study is to examine the role of the critical care nurse in the implementation of an 
antimicrobial stewardship programme in a private hospital in a low-middle income country.  
1.7 RESEARCH OBJECTIVES 
The objectives of this study are to examine: 
 The role of the critical care nurse in the implementation of an antimicrobial stewardship 
programme. 
 What interventions can be implemented by the critical care nurse to play a significant role in 
the implementation of an antimicrobial stewardship programme. 
1.8 RESEARCH METHODOLOGY 
A pre-and post-interventional study design was utilised for the research.  
1.9 SIGNIFICANCE OF THE STUDY 
The study is important in LMICs that do not have the tools nor the resources that are described by 
the literature for the implementation of an AMS programme. The existing skills of nurses have to be 
evaluated to establish what is needed to empower them to play a significant role in the AMS team 
and what interventions can be implemented successfully by nurses as part of the AMS team.  
Although nurses are not expected to replace clinical pharmacists or infectious diseases specialists, 
they can be educated and empowered to play a vital role in the clinical management team of a 
patient with infection. The role of the nurse needs to be recognised and acknowledged as a clinical 
practitioner.  
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1.10 SCOPE OR LIMITATIONS 
The study has been conducted in the critical care unit (CCU) of an acute care private hospital, in a 
LMIC over a period of thirteen months. The hospital has 247 operational beds and twelve critical 
care beds admitting both surgical and medical cases.  
All patients, fifteen years and older, admitted or transferred into the critical care unit from within the 
hospital or elsewhere and remained in the unit for more than 24 hours were included in the study.  
Monitoring of the appropriate surgical prophylaxis was not included in the study as most critical 
care nurses do not administer surgical prophylaxis; patients primarily receive prophylaxis in the 
general unit and are usually admitted to CCUs post-operatively if complications developed during 
or post-surgery.  
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CHAPTER 2 
LITERATURE REVIEW 
2.1 INTRODUCTION 
The research question and objectives were used as the basis for the topics and subjects of the 
literature review. The objective of the literature review was: 
 To establish what methodology and resources are currently used in low- to middle-income 
countries (LMICs) for the implementation of an antimicrobial stewardship (AMS) programme; 
 To determing what interventions are required for the implementation of an AMS programme 
internationally and specifically in LMICs; 
 To explore the role of nurses in the implementation of an AMS programme in LMICs. 
The literature review consists of the following subheadings: 
 The global extent of antimicrobial resistance;  
 Antimicrobial stewardship: Evidence-based solutions to reduce the problem; 
 The implementation of outcome and process measures to evaluate the impact of an AMS 
programme; 
 The results of the implementation of an AMS programme; 
 Training and education of healthcare workers;  
 The role of Infection prevention and control (IPC) in the implementation of an AMS 
programme; 
 The role of the nurse practitioner in the implementation of an AMS programme. 
2.2 SELECTION AND REVIEW OF THE LITERATURE 
The literature review was conducted over a period of 28 months. It commenced prior to submission 
of the research proposal and continued during the study period and data analysis. Various articles, 
position statements and guidelines were reviewed and analysed during this period. During the 
study period, the literature review expanded to explore different avenues that had not been 
previously included.  
The literature review was based on South African and international resources, with a focus on the 
implementation of AMS programmes in LMICs.   
Search engines such as Google Scholar and the electronic library of Stellenbosch University, 
SUNSearch (Stellenbosch University library and Information Service) and several data bases were 
utilised to obtain the material for the literature review, including, PubMed, ScienceDirect, Elsevier, 
ProQuest and EBSOhost (Elton B Stephens Company Research Database).  The majority of the 
articles were obtained from scientific journals; books, guidelines and reports were also included.  
The websites of the National Department of Health (NDoH), the Centre for Disease Control and 
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Prevention (CDC) and the World Health Organisation (WHO) were accessed in addition to 
published articles. Searches included resources from reference lists and key authors of other 
articles.  
Keywords that were employed included: antimicrobial stewardship programme, infection prevention 
and control, nurses, resource-limited countries, South Africa, interventions, training and 
prescribing.  A combination of these words was used. 
The inclusion and exclusion criteria were as follow: 
i) Inclusion criteria 
 Articles found with the key words that were published in accredited journals; 
 Open-access articles published online; 
 Editorials; and 
 Guidelines. 
ii) Exclusion criteria: 
 Studies that did not meet the inclusion criteria above; and 
 Abstracts of studies. 
2.3 THE GLOBAL EXTENT OF ANTIMICROBIAL RESISTANCE 
The use of antimicrobials has changed the world and the way in which medicine has been 
practiced since its development.  It enabled other medical interventions such as chemotherapy, 
transplants and replacement surgery (CDC, 2014:3). Antimicribials are effective in treating 
infections, but the inapproporate use has lead to the development of resistance amongst the 
majority of available antimicrobials (Hurford et al., 2012: 203; Laxminarayan et al., 2013:1057). 
Inappropriate use of antimicoribials is not the only contributing factor to the development of 
resistance. It is part of the natural evolution of living organisms to develop resistance to therapeutic 
drugs (Davies & Davies, 2010:417).  As soon as an antibiotic is used widely, resistant strains of 
micro-organisms will develop, with increasing resistance to more drugs over time (Davies & 
Davies, 2010:419). A decrease in effective treatment and resistance to antibiotics of certain 
recognised pathogens were already observed by clinicians as early as 1940 and 1950 (Owens, 
2008:110). Other contributing factors to resistance are the use of antibiotics in food production and 
the transmission of resistant organisms in healthcare facilities (WHO, 2012:2). 
Antimicrobial resistance is a major public health threat that has the ability to affect current and 
future generations (Sahoo et al., 2010:629). Improvements in healthcare during recent years is 
threatened by antimicrobial resistance and the treatment of many common diseases is complicated 
by resistant organisms. Doctors regularly have to prescribe “last resort” antibiotics and these are 
often more expensive and difficult to obtain in LMICs. Resistance to all the treatment options for 
two common infections affecting millions of people , e.g. gonorrhaoe and tuberculosis (TB) have 
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been reported (WHO, 2015a:3).  As LMICs have a high burden of infectious diseases, antibiotics 
are vital for the treatment of these infections (WHO, 2015a:3). 
At the Commonwealth Wilton Park meeting it was stated that the increase in antimicrobial 
resistance is a worldwide risk with detrimental effects on medical, economic and social wellbeing of 
global communities (Foreign & Commonwealth Office, 2015:1). The World Economic Forum 
highlighted the rapid spread of antimicrobial resistant pathogens and the economic and social 
impact that it has on communities as a global risk for 2015 (World Economic Forum, 2015). A 
global action plan is required, with all countries aligning their own strategies with the global action 
plan (Foreign & Commonwealth Office, 2015:1).  
A call was made for an urgent global and national multi-sectoral response (WHO, 2011; WHO, 
2012:2). On March 27 2015, the World Health Organisation (WHO) released a draft global action 
plan on antimicrobial resistance, stating that antimicrobial resistance (AMR) is a significant threat 
to human health (WHO, 2015a:1). AMR impacts negatively on the global economy and increases 
the cost of healthcare delivery (WHO, 2015a:1). The extent and impact of AMR in sub-Saharan 
Africa is unknown due to ineffective surveillance programmes, insufficient data and a lack of 
research in the field (Okeke et al., 2005a:481; Omulo, Thumbi, Njenga & Call, 2015:1; Mendelson 
& Matsoso, 2015:325).  The high burden of endemic infectious diseases demands the use of more 
antimicrobials and has a negative impact on already limited healthcare resources. Inadequate 
laboratory support and healthcare workers that have limited training on antimicrobial prescribing 
and usage are aggravating the problem (Omulo et al., 2015:1-2).  
South Africa has a high burden of infectious diseases and the additional burden of Human 
immunodeficiency virus (HIV) and TB leads to an increase in the use of antimicrobials, contributing 
to the pressure on the healthcare system (Mendelson & Matsoso, 2015:54).  The impact of 
bacterial and fungal infections remains unknown due to an inadequate surveillance system and 
high empiric usage of antimicrobials.  The unavoidable result of such a high burden of infections 
and antimicrobial usage is the development of resistance (Mendelson & Matsoso, 2015:55). South 
Africa was recently mentioned as one of the countries contributing significantly to antimicrobial 
consumption, especially in the utilisation of two “last resort” drugs, namely carbapenems and 
polymixins (Van Boeckel, Gandra, Ashok, Caudron, Grenfell et al., 2014:742). The implementation 
of the Antimicrobial Resistance National Strategy Framework (ARNSF) is an urgent matter and the 
interventions that are proposed in the strategy document (SA NDoH, 2014b) can be duplicated in 
healthcare systems of other middle-income countries (Mendelson & Matsoso, 2015: 54). 
In a prospective study conducted by Paruk et al. (2012:613), the antimicrobial prescription 
practices in CCUs of public and private hospitals in South Africa were evaluated to determine the 
relationship with patient outcomes. It was found that in 73.4% of patients, antimicrobials were 
initiated during their stay in CCU and that 55% of patients initially received an inappropriate drug. 
In 23.9% of patients, therapy was de-escalated and the duration of treatment was inappropriate in 
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72% of the cases. Some patients received up to ten different types of antimicrobials 
simultaneously.  The authors concluded that the finding of the study demonstrates the lack of 
knowledge and insight regarding the appropriate use of antimicrobials amongst doctors working in 
CCUs in the public and private sector in South Africa and that drastic measures are necessary to 
review current antimicrobial prescription practices to prevent further development of antimicrobial 
resistance (Paruk et al., 2012:615). 
Suleman and Meyer (2012:44) stated that an urgent situational analysis was required to 
consolidate all available information related to AMR to enable the identification of inefficiencies and 
areas for improvement (Suleman & Meyer, 2012:44). National and international interventions are 
required to establish a more accurate assessment of the problem and to implement interventions to 
reduce the development and spread of AMR organisms (Okeke et al. 2005a:481). 
Poverty is the major driving force for the use of leftover medicine, incomplete courses and self-
medication with antibiotics (Sahoo et al., 2010:636). Paruk et al. (2012:613) stated further that the 
inappropriate prescribing patterns of doctors and misuse of antimicrobials is the main contributor to 
the development of antimicrobial resistance. These findings are in line with published studies from 
other LMICs (Sahoo et al., 2010:1; Al-Tawfiq, Stephens & Memish, 2010:767; Okeke, Lamikanra & 
Edelman, 1999:24; Radyowijati & Haak, 2003:733-734). 
2.4 ANTIMICROBIAL STEWARDSHIP: EVIDENCE-BASED SOLUTIONS TO REDUCE THE 
PROBLEM  
The growing increase in resistant pathogens requires a consolidated strategy to prevent the further 
spread of resistant pathogens (Okeke et al., 2005b:568).  Various international guidelines 
recommend the implementation of antimicrobial stewardship (AMS) programmes to monitor 
antimicrobial usage and the prescribing habits of healthcare providers, to improve patient 
outcomes (Dellit et al., 2007:159; CDC, 2014:3-4; Institute for Healthcare Improvement, 2012; 
WHO, 2012:2-3; WHO, 2001:1-2; Society for Healthcare Epidemiology of America (SHEA), 
Infectious Diseases Society of America (IDSA) & Pediatric Infectious Diseases Society (PIDS), 
2012:322). 
Antimicrobials stewardship (AMS) refers to the implementation of specific interventions to improve 
clinical outcomes and to minimise the unintended consequences of inappropriate antimicrobial 
usage with the subsequent development and transmission of antimicrobial resistant pathogens 
(Dellit et al., 2007:159). The implementation of simple interventions can lead to a substantial 
reduction in cost and the utilisation of antimicrobials and is therefore feasible in LMICs (Goff et al., 
2012:587).   
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The WHO Global Strategy for Containment of Antimicrobial Resistance (WHO, 2001:1-2) 
recommended the following actions: 
 Implement a comprehensive national plan; 
 Strengthen surveillance programmes and laboratory support; 
 Ensure continuous availability of necessary medication of good quality; 
 Regulate and encourage appropriate use of medication, including in agriculture; 
 Enhance infection prevention and control (IPC); and 
 Encourage and support research and development of new resources and support material. 
In the Draft global action plan on antimicrobial resistance of the WHO (WHO, 2015a: 2) the 
following strategic objectives are highlighted: 
 Improve awareness and understanding of antimicrobial resistance; 
 Improve knowledge about the extent of the problem through surveillance and research; 
 Reduce incidence of infections; 
 Improve the use of antimicrobials; and 
 Implement sustainable programmes to reduce antimicrobial resistance. 
The draft global action plan should be used as a framework for countries to develop their own 
programmes to prevent antimicrobial resistance (WHO, 2015a:3). 
The CDC (2014:4) further recommended that the following Core Elements should be implemented 
in an antimicrobial stewardship program: 
 Leadership commitment and the provision of necessary resources such as human, financial 
and information technology; 
 Accountability: A physician leader with a knowledge of infectious diseases and/or 
antimicrobial stewardship who is responsible for implementation of the programme and the 
outcome; 
 Drug Expertise such as a pharmacist with knowledge of infectious diseases or antimicrobial 
stewardship who is responsible to improve antimicrobial usage; 
 Action: Implement at least one of the recommended actions at a time; 
 Tracking and monitoring of antimicrobial prescribing and pathogen resistance; 
 Reporting:  Doctors, nurses and all relevant personnel need to be informed about antibiotic 
use and resistance patterns; and 
 Education programmes to increase knowledge regarding prescribing and antimicrobial 
resistance. 
The Society for Healthcare Epidemiology of America (SHEA) recommended a multidisciplinary 
team led by a physician for the implementation of an AMS programme. It is important that at least 
one member of the team is trained in antimicrobial stewardship. The team should include a 
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physician, pharmacist, clinical microbiologist and infection prevention and control (IPC) practitioner 
(SHEA, IDSA & PIDS, 2012:324). 
In the recent Wilton Park meeting report (2015), countries were requested to formulate and 
coordinate a response to the increased problem of antimicrobial resistance and the threat that it 
poses to human and animal life (Foreign & Commonwealth Office, 2015: 3-10). 
Some of the key discussion points were (Foreign & Commonwealth Office, 2015: 3-10): 
 Antimicrobial resistance in humans, animals and the environment; 
 Political leader support and national and international awareness of the problem; 
 Improvement of surveillance systems to ensure adequate knowledge about the extent of the 
problem to be able to formulate scientifically proven interventions; 
 The importance of behavioural change to ensure sustainable improvement; 
 Access for communities to effective antimicrobials that are used appropriately in both 
humans and animals; 
 Effective IPC programmes to prevent the transmission of resistant pathogens;  
 Research and funding for new antimicrobials and rapid diagnostic tests. 
South Africa is facing a similar problem with resistance. The Antimicrobial Resistance Background 
Document of the National Department of Health (SA NDoH, 2014a: 1-2) stated that there is an 
increase in resistant pathogens that cause severe infections; treatment options are limited and no 
new antibiotics are available for the treatment of Gram-negative infections (SA NDoH, 2014a:8-9; 
Mendelson et al., 2012: 607; Brink, Feldman, Richards, Moolman & Senekal, 2008:586). Although 
AMS activities are reported in South Africa, there are limitations due to inadequate resources, 
insufficient surveillance programmes, lack of clinical pharmacists, infectious diseases specialists 
and IPC practitioners (SA NDoH, 2014b:9-16). 
Dr Aaron Motsoaledi, South African Minister of Health, requested that “implementation of 
antimicrobial stewardship programmes should be prioritised locally and internationally, due to the 
risk of antimicrobial resistance to public health” (SA NDoH, 2014b:3).  He further agreed to invest 
in sustainable health systems and to collaborate to strengthen capacity and systems (Chioro, Soll-
Seck, Hoie, Moeloek, Motsoaledi, Rajatanavin & Touraine, 2015:439). 
The goals of the Antimicrobial Resistance National Strategy Framework (ARNSF) (SA NDoH, 
2014b:8-9) are:  
 “To define the principles of  interventions needed to preserve the effectiveness of 
antimicrobials for future generations; 
 To improve the appropriate use of antibiotics in human and animal health;  
 To improve the effective management of antibiotic resistant pathogens and prevent their 
transmission; 
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 To create an enabling environment for the successful and sustainable implementation of the 
strategic objectives”.  
The ARNSF consists of four strategic objectives and four key enablers as demonstrated in 
Figure 2.1.  
 
Figure 2.1: National Strategy Framework 2014-2024 
Source: SA NDoH, 2014b:9. 
The key messages are that IPC programmes should be improved; antimicrobials should be used 
appropriately; that education of healthcare workers in AMR is of vital importance; and that 
expertise in AMS is required to assist with implementation of AMS programmes. Accredited 
training modules must be developed and more IPC practitioners, microbiologists and infectious 
diseases specialists must be trained and appointed in healthcare facilities (SA NDoH, 2014b:11-
14). 
Recommended strategies to prevent further development of resistance are complicated to 
implement in LMICs and require skilled personnel (Okeke et al., 2005b:568).  Okeke et al. 
(2005b:568) further stated that there is limited published evidence of successful and sustainable 
AMS programmes in these countries. Based on the literature, it is further not clear what tools and 
resources are required for the successful implementation of an AMS programme in LMICs as 
recommended by international organisations (Dellit et al., 2007: 159-172). Clinical teams consisting 
of clinical pharmacists and infectious diseases specialists responsible for AMS programmes are 
uncommon in LMICs.  
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The majority of facilities in South Africa have access to a clinical microbiologist or pathologist, an 
IPC practitioner, pharmacist and registered nurses.  Microbiology laboratories play an important 
role in AMS programmes (Goff, 2011:17; Lowman, 2015:359). Apart from the correct analysis of 
specimens, the clinical microbiologist can play a significant role in the compilation and 
interpretation of unit specific antibiograms, which is an important aspect in the implementation of 
an AMS programme. Organism- and resistance profiles differ substantially between critical care 
units and the rest of the hospital. This information will assist with the development of local 
treatment protocols and with the correct empiric treatment (Goff. 2011:17; Lowman, 2015: 360; 
Ramsamy, Muckart & Han, 2013:371). Kothari, Sagar, Panigrahi and Selot found that daily rounds 
by clinical microbiologists in the absence of infectious diseases specialists and clinical pharmacists 
in India, has led to an improvement in the appropriate use of antimicrobials, reduction in the cost of 
antimicrobials and no negative impact on the outcomes of patients with sepsis (Kothari et al., 
2008:1187). 
Yam et al. (2012:1142) investigated the implementation of an AMS programme in rural community 
hospitals without an infectious diseases physician and a few clinical pharmacists in the United 
States of America. As part of the implementation of the programme, infectious diseases physicians 
located away from the site were consulted weekly and additional clinical pharmacists were 
appointed or trained. Relevant staff members, including medical practitioners, were trained on the 
use of antimicrobials (Yam et al., 2012: 1142).  
Goff et al. (2012:587) recommended the implementation of simple interventions such as 
intravenous-to-oral-conversion, automatic therapeutic substitution and formulary restriction in 
LMICs. The money that is saved on antimicrobials can be utilised more efficiently in other areas of 
healthcare delivery in LMICs, such as immunisation and preventative care to reduce the burden of 
disease in these countries Goff et al., 2012:587). However, this study by Goff and colleagues 
focused only on the financial benefits of an AMS programme and not on the improvement in clinical 
outcomes. 
An essential part of an AMS programme is to take cultures prior to the administration of an 
antimicrobial and enhance daily communication between infectious diseases physicians and 
prescribers to encourage a reduction in the use of antimicrobials (Allen, 2005:197; Rimawi, Mazer, 
Siraj, Gooch & Cook, 2013:2099). Allen (2005:197) further stated that the clinical response of the 
patient should be considered when a decision is made about empirical treatment and that an IPC 
programme must be included in the implementation of AMS. The use of guidelines, restrictive 
formularies and education alone are not sufficient; good communication between team members is 
of vital importance for the success of the programme (Rimawi et al., 2013: 2099). 
In a systematic review Kaki, Elligsen, Walker, Simor, Palmay and Daneman (2011:1223) 
concluded that the implementation of AMS in CCUs was associated with a reduction in 
antimicrobial utilisation and subsequent cost, shorter duration of therapy and less inappropriate 
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antimicrobial use.  AMS interventions for more than six months were associated with a reduction in 
multidrug resistant organisms (Kaki et al., 2011:1223). This indicates that the implementation of an 
AMS programme is a long-term intervention and that there is no easy solution to the problem.  
Radyowijati and Haak (2003:733) analysed the evidence available to improve the usage of 
antimicrobials in LMICs.  They found that research on the impact of an AMS programme is limited 
and that future research is necessary to investigate the rational use of antimicrobials and the socio-
cultural aspect of antimicrobial usage (Radyowijati & Haak, 2003:733). 
Storey and colleagues (2012:2) stated that antimicrobial stewardship is a key strategy for 
addressing the problem of antimicrobial resistance and Clostridium difficile (C.diff). However, 
practical examples of successful stewardship programmes in community hospitals are limited in 
the reported literature (Storey et al., 2012:2). 
Although programmes such as the Integrated Management of Childhood Illnesses (IMCI) and 
Directly Observed short course Therapy (DOTs) for tuberculosis have been implemented 
successfully in LMICs, it is not possible to follow a “one size fits all” approach (Okeke et al., 
2005b:568). Okeke et al. (2005b:568) further stated that interventions do not always have an 
impact on the emergence of resistant pathogens or change behaviour. The majority of studies 
evaluating the effect of the implementation of AMS programmes have been conducted in well-
functioning and well-resourced healthcare systems in high-income countries (Okeke et al., 
2005b:568). Okeke et al. (2007:1644) concluded that many of the interventions implemented in 
LMICs focus on education, but these programmes have not been evaluated to measure their 
sustainable effectiveness. 
LMICs do not necessarily have clinical pharmacists and infectious disease physicians. There might 
be more effective and cost-efficient interventions that need to be explored further in these countries 
(Okeke et al., 2007:1644). 
It is important to establish what resources, skills and tools are available in LMICs that can be 
developed further to assist with the implementation of an AMS programme. A multi-disciplinary 
approach is required and scarce resources must be utilised more effectively (Allen, 2005:198). 
Nurses might be one of the resources that should be explored further. Nurses are constantly 
monitoring patients and are responsible for the administration of antimicrobials. They can 
potentially play an important role in the implementation and sustainability of an AMS programme 
(Royal College of Nursing, 2014:4; Abbo et al., 2012:370; Gillespie, Rodrigues, Wright, Williams & 
Stuart, 2013: 365). 
Nurses utilising a checklist might be able to assist with the implementation of an AMS programme. 
Weiss and colleagues (2013:1) found that using a checklist to remind prescribing physician led to a 
reduction in inappropriate antimicrobial prescriptions. Checklists are valuable tools in reducing 
errors of omission and assist with improving outcomes in critical ill patients (Weiss et al. 2013:1).  
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In an 18-month cohort study by Pronovost et al. (2006:2731) catheter-related bloodstream 
infections were significantly reduced utilising a checklist with five recommended evidence-based 
procedures. Similar methodology can be used for AMS programmes and nurses can be 
responsible for completing the checklist on a daily basis. 
The implementation of a care bundle or scientifically proven interventions for antimicrobial 
stewardship appears to have a positive impact on outcomes (Toth et al., 2010:746; Coll et al., 
2012:845; Patel, Lawson & Guglielmo, 2008: 219). Toth and colleagues (2010:746) demonstrated 
an increased in appropriate de-escalation from 72% to 90% (p=0.01) in a quasi-experimental 
study. Monthly in-service training programmes were included in the intervention and process and 
outcome measures are essential to evaluate the impact of the interventions (Toth et al., 2010:746; 
Coll et al., 2012:845).  
2.5 THE IMPLEMENTATION OF OUTCOME AND PROCESS MEASURES TO EVALUATE 
THE IMPACT OF AN ANTIMICROBIAL STEWARDSHIP PROGRAMME 
A key element of an AMS programme is to measure the impact of the programme on antimicrobial 
usage and resistant patterns of micro-organisms (WHO, 2012: 41). The purpose of measuring the 
impact of interventions is to establish whether it has any value and whether changes should be 
made to achieve the appropriate outcome. Quality improvement methodology using process and 
outcomes measures, with clear aims and objectives is the preferred method to measure the impact 
of interventions (Dellit et al. 2007:171; Patel, Lawson & Guglielmo, 2008:209; Nathwani et al., 
2011:24; Institute of Healthcare Improvement, 2015).  
Dellit et al. (2007: 161) recommended that both process and outcome measures should be part of 
the implementation of an AMS programme to measure the success and the impact on antimicrobial 
use and resistance patterns. A baseline should be established prior to the implementation of an 
AMS programme to monitor the progress of the interventions implemented over time (Owens, 
2008:125; SHEA, IDSA & PIDS, 2012:326).  Examples of such measures might be the prevalence 
of C.Diff rates, hang time, multi-cover and excessive duration of therapy (SHEA, IDSA & PIDS, 
2012:326; McGowan. 2012:332).   
Process measures are used to measure the degree to which a specific intervention changes a 
certain aspect of a programme (Dellit et al. 2007:161). An example will be to what extent were 
healthcare workers compliant to the different bundle elements that were implemented (Institute of 
Healthcare Improvement, 2015). Rules of run charts can be utilised to measure the impact of these 
interventions (Perla, Provost & Murray, 2011:46).  
Outcome measures on the other hand refer to the degree of success achieved with 
implementation, e.g. whether the processes implemented impact on the development of resistant 
organisms or on antimicrobial usage (Dellit et al. 2007: 161).  An example of a successful outcome 
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measure will be whether the implementation of an AMS programme had a significant reduction in 
Methicillin Resistant Staphylococcus aureus (MRSA) rates. 
McGowan (2012: 331) stated that historically AMS programmes mainly focused on process 
measures, such as the proportion of healthcare institutions that have implemented specific 
measures, the availability of a functional AMS team or the proportion of correct prescriptions 
according to guidelines or antibiograms. A reduction in cost of antimicrobials does not necessarily 
equate to an improvement in patient outcomes. It is recommended that stewardship programmes 
focus more on patient safety, improved clinical outcomes and a reduction in resistance (McGowan. 
2012:332; Goff. 2011:19).  
Pulcini, Defres, Aggarwal, Nathwani and Davey (2008:1384-1388) used a care bundle with four 
evidence-based elements to improve empiric antibiotic use. Improvement methodology was used 
to test and implement changes (Pulcini et al., 2008:1384-1388). A care bundle is a structured way 
of improving processes of care and patient outcomes through a set of evidence-based 
interventions. It proved that interventions implemented consistently improved patient outcomes 
(Institute of Healthcare Improvement, 2012:2). The authors acknowledged that the complete 
bundle needs to be consistently implemented to have an effect (Pulcini et al., 2008:1386). 
Selective application of the bundle will not result in the anticipated outcome. They further 
acknowledged that not all the elements in the bundle had adequate evidence to support its 
inclusion in the bundle (Pulcini et al., 2008:1386).  
The implementation of a bundle, together with training, improved IPC measures and a team 
approach; decreased antimicrobial therapy by 41%; and demonstrated a reduction in hyper-virulent 
C. diff from 51% to 13% (Patel, Lawson & Guglielmo, 2008:219). 
Using certain targeted antimicrobials as a process measure is an effective way of measuring 
outcomes.  It provides an indication of how many antimicrobials are used and the cost thereof 
(Owens, 2009:696). The use of defined daily dosage (DDD) is a reliable measure to standardise 
antimicrobial classification and consumption (WHO, 2012:11).  With the use of defined daily 
dosages, grams of antibiotics are converted into DDDs per 1 000 patient days and this data allows 
for benchmarking and comparison between different healthcare facilities (Owens, 2009:696; Dellit 
et al., 2007:171).  
Other examples of outcome measures are the number of correct prescriptions for antimicrobials, 
duration of therapy, as well as the incidence of colonisation or infection due to resistant pathogens 
(Arnold & Strauss. 2009:5). 
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2.6 THE RESULTS OF THE IMPLEMENTATION OF AN ANTIMICROBIAL STEWARDSHIP 
PROGRAMME 
Studies have demonstrated that the implementation of an AMS programme has the ability to 
reduce antimicrobial consumption, resistance and the development of healthcare-associated 
infections (HAIs).  
After an eight-year-old observational study, Dortch and colleagues demonstrated a reduction in 
HAIs due to multidrug resistant (MDR) Gram negative organisms from 37.4% (2001) to 8.5% 
(2008) and an overall reduction of 0.78 per 1 000 patient days (Dortch et al., 2011:15). 
Clinical pharmacists and weekly consultations with infectious diseases specialists in rural 
community hospitals demonstrated a significant reduction in antimicrobial usage (Yam et al. 
2012:1142; Storey et al., 2012:2). Healthcare-associated C. diff infections decreased from an 
average of 5.5 cases per 10 000 patient-days to 1.6 cases per 10 000 patient-days (Yam et al. 
2012:1146). Training of staff, including medical practitioners, on appropriate antimicrobial usage is 
essential (Yam et al., 2012:1148).  
Several authors had similar findings and were able to show a reduction in antimicrobial use and 
associated cost (Nowak, Nelson, Breidenbach, Thompson & Carson, 2012:1500; Malani, Richards, 
Kapila, Otto, Czerwinski & Singal, 2013:145).  An overall reduction in the rates of HAIs with C. diff 
(p=0.018) and Vancomycin Resistant enterococci (VRE) (p=0.0004) were reported (Nowak et al., 
2012:1504).  
The implementation of an AMS programme in a 535-bed community hospital led to a reduction in 
the cost of antimicrobials and Clostridium difficile rates. Important to note is that the hospital had 
two permanently-employed infectious diseases specialist and three clinical pharmacists (Malani et 
al., 2013:146 -148). This demonstrates the importance of adequate trained resources for the 
successful implementation of an AMS programme. 
Three years after the implementation of an AMS programme in a community hospital, Yu-Shiuan, I-
Fen, Yung-Fen, Pei-Ching, Yu-Chih et al. (2013:1072) reported a reduction in the cost of broad 
spectrum antimicrobials. Interventions implemented included training, multidisciplinary teamwork 
and feedback regarding outcomes measures. The clinical pharmacist and IPC practitioner played a 
major role in the multidisciplinary team (Yu-Shiuan et al., 2013:1072). 
Until recently, the majority of studies focused on the cost benefit of AMS programmes and not on 
the quality of studies and the improvement of clinical outcomes (McGowan, 2012:233-334). More 
evidence is needed to prove improved clinical outcomes and a reduction in AMR (McGowan, 
2012:335). 
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The implementation of a national AMS programme in Scotland proved to reduce C. diff infections 
and a restrictive antimicrobial policy appears to not have negatively impacted on the mortality rate 
(Nathwani, Sneddon, Patton & Malcolm, 2012:2). Nathwani and colleagues further highlighted the 
importance of clinical leadership and organisational accountability.  
In a systematic review done by Wagner, Filice, Drekonja, Greer, McDonald and colleagues 
(2014:1209), the authors concluded that various studies have been published demonstrating a 
decrease in antimicrobial usage, and associated reduction in the cost of antibiotics and reduction in 
resistant pathogens. However, there is less published data and limited strong evidence on 
improved clinic outcomes and sustainability of these programmes (Wagner et al., 2014:1209). 
2.7 TRAINING AND EDUCATION OF HEALTHCARE WORKERS 
Inadequate knowledge of prescribers and other healthcare workers is a major contributing factor to 
inappropriate antimicrobial usage (Pulcini & Gyssens, 2013:192; WHO, 2015a:3). Training on 
antimicrobials is traditionally directed at medical practitioners after graduation (Pulcini & Gyssens, 
2013:192). 
Training is an important element of an AMS program, especially if the programme needs to change 
behaviour and influence practice (Dellit et al., 2007:165; SHEA, IDSA & PIDS, 2012: 325). Training 
on antimicrobial prescribing should be part of the training curriculum of undergraduate medical 
students and other healthcare workers such as nurses and pharmacists (Pulcini & Gyssens 
(2013:192). Various methods such as e-learning modules, brochures, leaflets and lectures are 
available for training as passive training alone is not enough (Pulcini & Gyssens, 2013:192; CDC, 
2014:13; SHEA, IDSA & PIDS, 2012:325; Dellit et al. 2007:165: Nathwani et al., 2011:22).  
Interactive, participating training sessions provided by mentoring physicians have much more value 
and influence to change behaviour (Pulcini & Gyssens, 2013:199).  In a Cochrane review Arnold 
and Strauss (2009:13-14) found that interactive learning sessions such as workshops, outreach 
programmes, reminders, audit and feedback might be more beneficial than learning sessions 
through conference attendance and lectures.   
In a qualitative study conducted in India, Sahoo and colleagues concluded that it is important to 
improve physician and consumer knowledge and behaviour to use antimicrobials more 
appropriately and rationally (Sahoo et al., 2010:636). Gillespie et al. (2013:356-366) demonstrated 
that by providing additional training for nurses on AMS and the indications for therapy, they were 
able to play a significant role in the implementation of an AMS programme that lead to a 
subsequent reduction in Staphylococcus areus bloodstream infections. (Gillespie et al., 2013:356-
366). Similarly, Moongtui, Picheansathian and Senaratana (2011:107) stated that after training on 
IPC and AMS, nurses can play a role in AMS programmes, particularly through timeous notification 
of infections, isolation of patients and the implementation of transmission-based precautions, hand 
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hygiene compliance and environmental cleaning.  Improved knowledge has the ability to change 
behaviour (Moongtui et al., 2011:107).  
In an AMS training programme directed at rural hospitals, Kellie (2011:1181) found that using 
resources such as video conferences, electronic guidelines and articles, regular lectures with the 
opportunity to ask questions and share experiences, all participating rural hospitals increased their 
AMS activities with 38%.  One of the limitations of the study was that the sustainability and the 
impact of the interventions were not measured. The positive aspect of the study was that onsite 
training was provided to staff of rural hospitals without having to travel (Kellie, 2011:1181-1183). 
These aspects make a programme like this very favourable for implementation in rural and LMICs. 
Cisneros, Neth, Gil-Navarro, Lepe, Jimenez-Parrilla et al. (2014:83) demonstrated that there is 
value in using one-to-one counselling interviews with prescribers as part of a training programme 
to improve appropriate use of antimicrobials. Clinical data was reviewed during interviews and the 
treatment was compared to the clinical diagnosis, using a standardised questionnaire (Cisneros 
et al., 2014:83).  A limitation of the study for implementation in LMICs is that the consulting team 
consisted out of infectious diseases specialists, clinical pharmacists, intensive care and 
preventative medicine specialists, paediatricians and a microbiologist (Cisneros et al., 2014:83). All 
of these resources are not readily available in the majority of hospitals in LMICs.  Another limitation 
of this study was that the clinical outcomes were not measured, but only the usage of 
antimicrobials (Cisneros et al., 2014: 84). 
Budwall (2010:116) stated that pharmacists specialising in infectious diseases or antimicrobials are 
in an ideal position to train doctors and nurses on the appropriate use of antimicrobials.  Other 
healthcare professionals should be included in the training programmes (Budwall, 2010:116).  
An effective training programme can contribute to a reduction in HAIs and the transmission of 
communicable diseases, as mentioned by Mehtar, Marais and Aucamp (2011:1-7).  It is important 
to conduct a baseline assessment prior to commencing with a training programme to establish the 
existing level of knowledge. Mehtar et al. (2011: 2-3) highlighted the fact that senior management 
support is vital for the successful implementation of a training programme, but that the rapid 
turnover of staff has a negative impact on training programmes (Mehtar et al., 2011:1-7). 
The CDC (2014:13) and SHEA (2012:325) recommended that information about facility-specific 
antimicrobial usage should be shared with clinicians and other healthcare workers using 
presentations, newsletters and electronic communication to improve prescribing habits. Reviewing 
of cases should be used as an opportunity to educate personnel.  
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2.8 THE ROLE OF INFECTION PREVENTION AND CONTROL IN THE IMPLEMENTATION 
OF AN ANTIMICROBIAL STEWARDSHIP PROGRAMME 
Antimicrobial resistant bacteria are transmitted in healthcare facilities and have the potential to 
contribute to the increase in antimicrobial resistance worldwide (WHO, 2012:64; WHO, 2015a:3). 
Insufficient IPC programmes, including inadequate policies and procedures, challenges with design 
and infrastructure, inadequate staffing and skills mix and the behaviour of healthcare workers 
contribute to the problem. Patient and disease profiles further have an impact and contribute to the 
extent of the problem (WHO, 2012:65). 
The Association for Professionals in Infection Control and Epidemiology (APIC) and the Society for 
Healthcare Epidemiology of America (SHEA) stated in their position paper that IPC programmes 
play a vital role in the implementation of an antimicrobial stewardship (AMS) programme and the 
prevention of the spread of multidrug resistant organisms (MDROs) (Moody, Cosgrove, Olmsted, 
Septimus, Aureden et al., 2012:94). A renewed focus is necessary to highlight the importance of 
IPC programmes and to recognise the importance of collaboration with other healthcare services 
(Royal College of Nursing, 2014:5). 
To implement and maintain a successful and sustainable IPC programme, a multimodal and 
multidisciplinary programme is needed to ensure a system- and behavioural change of healthcare 
workers (WHO, 2012:65: Chalfine et al., 2012:1). This includes monitoring of isolation precautions, 
an AMS programme, availability of alcohol-based hand rubs and feedback to healthcare providers. 
These successful interventions reduced antimicrobial usage by 31% and healthcare-associated 
Methicillin Resistant Staphylococcus aureus (MRSA) bacteraemia by 93% (Chalfine et al., 2012:1). 
The Wilton Park report (Foreign & Commonwealth Office, 2015:6) recommended that IPC 
programmes are reviewed and that the spread of resistance pathogens through ecosystems and 
into the food chain should be explored. Sanitation in LMICs should improve and healthcare 
systems should be strengthened in order to prevent transmission of resistance. Hygiene practices 
and knowledge must be improved, with emphasis on the importance of hand hygiene, in both the 
community and healthcare facilities. Other important areas that need to be targeted are the new 
technology of rapid diagnostic tests and improved vaccination programmes (Foreign & 
Commonwealth Office, 2015:6). 
Mendelson and colleagues (2012: 607) stated that IPC is a key element in an AMS programme to 
prevent the transmission of resistant pathogens in healthcare facilities (Mendelson et al., 2012:607; 
WHO, 2012:68; Foreign & Commonwealth Office, 2015:6; Brink et al., 2008:590). IPC is not only 
the responsibility of IPC practitioners, but of every healthcare worker and accountability of all in the 
healthcare industry is required (Mendelson et al., 2012:607; Chalfine et al. 2012:1; WHO, 
2012:68). Other important factors are screening and decolonisation, readmission alert systems that 
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notify healthcare workers if patients colonised or infected previous with MDROs are re-admitted, 
environmental cleaning and education of healthcare workers (WHO, 2012:68). 
The WHO (2015a:5) recommended that a good IPC programme can be a cost-effective measure 
to prevent the transmission of AMR organisms and can be implemented in all healthcare settings, 
including LMICs.   
2.9 THE ROLE OF THE NURSE PRACTITIONER IN THE IMPLEMENTATION OF AN 
ANTIMICROBIAL STEWARDSHIP PROGRAMME 
Nurses play a significant role in the prescribing and administration of antimicrobials in South Africa 
and other LMICs. The South African Nursing Council allows nurses to prescribe and dispense 
medication according to the Standard Treatment Guidelines and Essential Medicine list in primary 
healthcare settings after the successful completion of a suitable training programme (SA NDoH, 
2015:1; Essack, Schellack, Pople, Van der Merwe, Suleman, Meyer, Gous & Benjamin, 2010:564). 
Nurses are widely used in LMICs to initiate treatment for tuberculosis as well as antiretroviral 
treatment for HIV and the syndromic treatment for sexually transmitted diseases (Colvin, Fairall, 
Lewin, Georgeu, Zwarenstein, Bachmann, Uebel, Bateman, 2010:212; Georgeu, Colvin, Lewin, 
Fairall, Bachmann, Uebel, Zwarenstein, Draper, Bateman, 2012:11). However, currently nurses are 
not used in acute care settings in South Africa to prescribe antimicrobials. At present, prescribing 
antimicrobials is the prerogative of the treating physician alone.  
Although antimicrobial stewardship programmes follow a multi-disciplinary approach, it mostly 
includes a clinical pharmacist, physician, infectious diseases specialist, microbiologist and possibly 
an infection prevention and control (IPC) practitioner (Tamma & Cosgrove. 2011:245).  The 
involvement of registered nurses has been limited (Edwards, Drumright et al., 2011:6; Tamma & 
Cosgrove, 2011:245). A large proportion of healthcare workers consist out of nurses and their role 
and contribution in the implementation of AMS programmes should be recognised and 
acknowledged (Royal College of Nursing, 2014:4). In order to implement a successful AMS 
programme, all disciplines within a healthcare setting have to be included in the implementation of 
the programme (Royal College of Nursing, 2014:4). Senior nurses should be included as core 
members of an antimicrobial stewardship team (Ladenheim, Rosembert, Hallam & Micallef, 
2013:47).   
Curry and colleagues (2014:6-7; CDC, 2014:6) further stated that nurses can play a significant role 
in the implementation and adherence to IPC principles, education, vaccination programmes, quality 
improvement projects, by obtaining specimens prior to commencement of an antimicrobial and to 
ensure that the correct antimicrobial is administered on time and documented (Royal College of 
Nursing, 2014:6-7; CDC, 2014:6). Nurses can review prescription charts, monitor patients, interpret 
blood results and evaluate the duration of therapy.  They can further confirm allergies and 
administer the correct drug at the correct time for the correct duration (Ladenheim et al., 2013:48) 
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and discuss the results and indication of antibiotic treatment with medical practitioners, as well as 
the duration of treatment (CDC, 2014:6).  
Edwards, Loveday, Drumright and Holmes (2011:4) stated that nurses provide the most consistent 
patient care and that they should play a bigger role in the multidisciplinary collaboration to 
implement antimicrobial stewardship. Nurses can potentially be a cost-efficient resource. 
Furthermore, Edwards, Drumright et al. (2011:9) noted that the role of the nurse in the 
implementation of an antimicrobial stewardship programme is not clear and it should be 
investigated further since reducing antimicrobial resistance extends beyond the responsibility of 
prescribing physicians and pharmacists. 
As patient advocates, nurses have a responsibility to ensure that antimicrobials are prescribed 
appropriately and to educate patients on the correct use of antimicrobials (Edwards, Loveday et al., 
2011:4; Crombie, 2012:16). Although Crombie’s study was based on experiences in primary 
healthcare settings, it can be applied in acute care settings. Crombie (2012:19) further stated that 
nurses can advise patients on the indications for an antibiotic, the advantage of flu vaccines for 
high-risk groups and the importance of following the instructions on when and how to take the 
prescribed medication. 
A key responsibility of nurses is to administer medication (Gillespie et al., 2013:356; Budwall, 
2010:116; Moongtui et al., 2011:104).  They are in an ideal position to monitor and audit 
prescriptions and Gillespie et al. (2013:365-367) found that nurses play an important role in 
questioning the appropriateness of treatment, but that additional training might be required. 
Barriers to their inclusion in the AMS team needs to be clarified and their role in the 
multidisciplinary team should be established (Edwards, Drumright et al., 2011:9). 
Gillespie et al. (2013:354) emphasised that nurses should not take the responsibility of prescribing 
the antimicrobial, but should ask questions about the appropriateness of the prescription. Their 
study highlighted the fact that additional training on antimicrobials is required (Gillespie et al. 
2013:365-365). Influencing or confronting clinicians about prescribing practice might be challenging 
for nurses in the hierarchical environment of healthcare. Charani, Castro-Sanchez, Sevdalis, 
Kyratsis, Drumright, Shah and Holmes (2013:189-194) found that senior doctors will ignore policies 
if they feel it is undermining their authority and questioning their knowledge and decision-making 
ability.  Policies will be followed if endorsed by senior colleagues. Nurses might therefore be 
hesitant to prompt and correct doctors. Healthcare workers in general are hesitant to question 
prescriptions of colleagues (Charani et al., 2013:189-194).  
Budwall (2010:116) stated that nurses can remind doctors to switch from intravenous to oral 
therapy, monitor therapeutic drug results and inform the physician about the results (Budwall, 
2010: 116; Ladenheim et al., 2013:47).  
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According to Charani, Cooke and Holmes (2010: 2276), nurses should be trained and educated 
regarding antimicrobial usage and be encouraged to participate in AMS programmes. Nurses, 
together with pharmacists, are the most consistent workforce. Healthcare workers need to be more 
actively involved in the decision-making process in order to make a sustainable change in 
prescribing practices (Charani et al., 2010: 2276). 
The question is whether the registered nurse working in the CCU can be empowered to play a 
significant role in the implementation of AMS programmes in facilities that do not have the 
resources as recommended in the literature (Dellit et al. 2007: 159-173).   
In an anonymous electronic survey done by Abbo and colleagues (2012:373) the perceptions, 
attitudes and knowledge about antimicrobial use and resistance were tested amongst nurses in a 
university-affiliated hospital. Critical care nurses scored higher then nurses in other disciplines in 
the knowledge question (82% vs. 64%; p<0.002). The study concluded that AMS programmes 
require a team approach and that the role of nurse practitioners and more specifically critical care 
nurses, should not be underestimated and explored further (Abbo et al., 2012:376).  
Friedman (2013:400) stated that the implementation of an AMS programme is a long-term 
intervention that needs to be sustainable to be effective.  He furthermore stated that LMICs might 
not have all the necessary resources for the implementation of an AMS programme as described in 
the literature (Friedman, 2013:410). Nurse practitioners are already responsible for the prescription 
of antibiotics in primary healthcare settings in many countries. The inclusion of nurse practitioners 
in AMS programmes might improve the effective use of antimicrobials and their role needs to be 
explored further (Abbo et al., 2012:373; Edwards, Drumright et al., 2011:9).  
2.10 CONCLUSION 
South-Africa has to identify resources to implement a national AMS programme as described in 
several guidelines (Dellit et al., 2007; CDC, 2012; WHO, 2012; SA NDoH, 2014b:8-9). Private 
hospitals in South Africa have very few clinical pharmacists and even fewer infectious diseases 
specialists. Expertise for the implementation of an AMS programme is limited and the utilisation 
and training of alternative resources should therefore be explored to successfully implement an 
AMS programme. The CDC (2014:4) recommended that leadership commitment and the provision 
of necessary resources are essential for the implementation of an AMS programme. It is presently 
not clear which interventions can be successfully implemented in LMICs to reduce AMR. The 
majority of studies have been conducted in well-resourced and well-developed countries. Studies 
conducted in India and China indicated that training and improved IPC practices are important 
interventions to reduce the transmission of antimicrobial resistance (Yu-Shiuan et al., 2013:1072, 
Moongtui et al., 2011:107, Sahoo et al., 2010: 629). It is uncertain which interventions related to 
AMS can be implemented by nurses. 
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In addition to current resources, critical care nurses should be included in the AMS team, 
considering the availability of other healthcare workers. Their role in the AMS team should be 
clarified and it should be established whether the utilisation of a checklist with evidence-based 
quality indicators can assist with the implementation of the programme.  
Edwards, Drumright et al. (2011:6) suggested that nurses can play a role and can be responsible 
for specific activities such as the monitoring of duration of treatment, indication for antimicrobial 
treatment, prompts to de-escalate and switch from oral to intravenous treatment. Many of these 
interventions are performed by physicians and pharmacists in well-resourced countries, but can be 
executed by nurses.  Nurses are involved in all levels of patient care and are in a position to 
continuously monitor the condition and treatment of the patient. The authors concluded that nurses 
can play a key role in AMS teams through the implementation of evidence-based measures and 
ensuring patient safety in healthcare facilities (Edwards, Drumright et al., 2011:6). 
The following chapter gives an overview of the research methodology employed in this study. 
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CHAPTER 3 
RESEARCH DESIGN AND METHODOLOGY  
3.1 INTRODUCTION 
The previous chapters provided the background to the study including a review of the literature. 
The insufficiencies in the literature were highlighted. The aim of the study is to address some of the 
limitations identified in the research question.  
Chapter 3 provides a detailed description of the study design and methodology that was followed 
to investigate the role of the critical care nurse in the implementation of an antimicrobial 
stewardship programme. 
3.2 STUDY DESIGN 
A quantitative method was used to prove the research question due to the measurable variables 
that can be used to objectively answer the research question and reach unbiased conclusions 
(De Vos, Strydom, Fouché & Delport, 2011:63). 
A pre- and post-intervention study design was utilised for this research. The main reason for the 
selection of this specific study design was to establish whether any changes took place after the 
implementation of certain interventions. A control group was furthermore not included in the study 
to limit possible bias. It would have been problematic to find a hospital with a similar organism and 
disease profile. Nurses furthermore have different levels of knowledge and hospitals have different 
interpretations of policies and procedures.  Although a control group would have been preferred 
and another unit in the hospital could have been used as a control, the researcher wanted to test 
the proposed interventions on a small scale to establish if there is merit in the interventions, before 
rolling it out to more departments in the hospital. A CCU is normally a more controlled environment 
and therefore provides a more favourable environment for interventions where daily checks are 
required.   
3.3 STUDY SETTING 
The study was conducted in the CCU of an acute care private hospital in the Limpopo province, 
South Africa from 1 May 2014 until 31 May 2015. The hospital has 247 operational beds, eight 
operating theatres and twelve critical care beds.   
Both surgical and medical patients are admitted in the CCU with the majority being medical 
patients (60%). The bed occupancy in the unit is 84.81% with a median length of stay (LOS) of 
5.78 days. Any specialist with admission rights are allowed to admit patients to the CCU. 
The hospital has six physicians and five pharmacists. Medical practitioners are not employed by 
the hospital. They work as independent practitioners. There is no infectious diseases specialist or 
clinical pharmacist working at the hospital. 
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A clinical microbiologist has started visiting the hospital once a month from May 2014 and in 
addition to training, conducts a ward round with treating physicians and makes recommendations 
about treatment plans.  
The staff component of the CCU consists of a unit manager, senior registered nurse, thirteen 
registered nurses, six enrolled nurses and two enrolled nurse assistants, as well as a ward 
administrative assistant. Three of the registered nurses have a critical care qualification.   
A situational analysis preceded the study. No antimicrobial stewardship (AMS) programme had 
been implemented prior to commencement of the study. The main barrier was the unavailability of 
skilled personnel such as a clinical pharmacist, infectious diseases specialist or clinical 
microbiologist; all key resources in the implementation of an AMS programme.  
3.4 PARTICIPANTS 
The records of all patients fifteen years of age and older admitted or transferred into the CCU from 
other departments in the hospital or other healthcare facilities for longer than 24 hours were 
reviewed as part of the study. Patients admitted for post-operative monitoring were excluded from 
the study, except if the admission exceeded 24 hours due to post-surgery complications.  The 
rationale behind excluding post-operative patients was based on the fact that antibiotics are not 
routinely administered, unless surgical prophylaxis is indicated. Prophylaxis is not generally 
administered for longer than 24 hours. The records of 407 patients were included in the pre- and 
post-intervention record review and a checklist was completed for all patients admitted to the CCU 
during the study period of 13 months.    
Nurses working in the unit were included in the pre- and post-training knowledge assessment, 
training and data collection. Written consent was obtained from both the nurses taking part in the 
study as well as the hospital (Refer to Appendix A for the participants’ information and consent 
form). Demographic information such as age, nursing qualifications and years of experience was 
collected. Date of birth was used to identify nurses who took part in both the pre- and post-
assessment. All information was kept confidential.   
The role of the nurses in the study was to implement a checklist and monitor on a daily basis 
whether there was adherence to the elements detailed on the checklist. They were furthermore 
responsible to ensure that the interventions stipulated on the checklist were executed and that it 
was not merely a checklist. The nurses were responsible for the following: 
 Collect specimens prior to the commencement of an antimicrobial; 
 Ensure that an antimicrobial was administered as soon as possible after a prescription was 
written; 
 Remind the treating physician to de-escalate once an organism was cultured and the 
resistance pattern was known; and 
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 Remind the treating physician to review the necessity of treatment as well as the necessity of 
the invasive device. 
The role of the researcher in the study was to coordinate the implementation of the programme, 
training of the nurses, auditing of adherence to IPC practices, collection and collating of data. The 
study hospital was visited three times during the study period and continued support and 
communication were provided via teleconferences and e-mail.  
3.5 INTERVENTIONS 
Several interventions were implemented as part of the study, namely: 
 Infection prevention and control audits; 
 Training of healthcare workers; 
 Monthly ward rounds conducted by a clinical microbiologist; and  
 Nurses utilising a checklist to monitor specific measures daily to measure compliance to 
evidence-based interventions as part of an antimicrobial stewardship programme.  
Prior to the intervention, the study hospital was visited and the purpose of the study explained to all 
the stakeholders. During the visit, the critical care nurses, unit manager and IPC practitioner 
received training on basic IPC principles and antimicrobial stewardship. The checklist was 
discussed in detail as well as the importance of each measure on the checklist and the purpose of 
the daily completion and adherence to the different measures. The clinical microbiologist was 
introduced on the second visit and provided training on AMS to the medical practitioners and 
nurses in the form of presentations on a monthly basis. Ward rounds were conducted during his 
visits and the treatment of individual patients was discussed. The medical practitioners welcomed 
the discussions and continued to consult the clinical microbiologist telephonically.  
The interventions that were implemented are discussed individually in detail in this chapter.  
3.5.1 Record review 
A retrospective record review was conducted by the researcher of patients admitted to the unit 
eight months prior to the interventions to establish a baseline and to ensure a large enough sample 
size (1 October 2013 to 31 May 2014) and repeated the same period at the end of the study. 
The following information was collected:  
 Demographic data such as age and gender; 
 Length of stay in the critical care unit; 
 Positive specimen prior to initiation of antimicrobial therapy; 
 Duration of antimicrobial therapy; and 
 Amount of antimicrobials prescribed.  
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3.5.2 Knowledge assessment  
A baseline knowledge assessment utilising a paper-based questionnaire was done on registered 
and enrolled nurses working in the CCU to establish their knowledge about AMS and IPC prior to 
implementation of the different interventions (Refer to Appendix C).   The knowledge assessment 
was repeated at the end of the study.  The purpose of the knowledge assessment was to establish 
whether training assisted with an improvement in knowledge about IPC and AMS and improved 
adherence to IPC practices. 
3.5.3 Infection Prevention and Control Audits 
The researcher conducted an IPC audit pre-and post-intervention to establish compliance to IPC 
principles (Refer to Appendix E). The audit did not only evaluated environmental cleaning and 
hand hygiene, but included aspects related to training and surveillance.  
3.5.4 Checklist with daily measures 
A checklist measuring adherence to specific evidence-based interventions related to antimicrobial 
stewardship was completed daily by the critical care nurses (Refer to Appendix D). Completion of 
the checklist was however only part of the intervention. The nurses had to ensure that the 
necessary action had to be taken to ensure adherence. The completion of the checklist 
commenced on 1 June 2014 and concluded on 31 May 2015. 
The following elements were included in the checklist: 
i) Hang time 
Hang time refers to the time from the generation of the prescription until the administration of the 
first dose of antimicrobials.  Several studies and guidelines have demonstrated the importance of 
prompt administration of a broad-spectrum antimicrobial in critically ill patients with severe sepsis 
to reduce mortality  
ii) Culture before treatment 
Taking samples for microbiological culture before treatment was the second element on the 
checklist. The significance of this measure is to ensure that the most appropriate and narrow-
spectrum antibiotic is prescribed for the organism that has been cultured and the clinical condition 
of the patient  
iii) De-escalation of therapy 
De-escalation of antimicrobial therapy was monitored and the significance of the measure was to 
ensure that patients receive targeted therapy as soon as the sensitivity of the organism had been 
established  
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iv) Duration of therapy  
Duration of therapy was measured daily. In order to prevent resistance, treatment with an 
appropriate antibiotic needs to be as short as clinically possible. The nurse reminds the doctor at 
day seven to stop therapy. 
v) Number of antimicrobials prescribed and administered simultaneously was another daily 
measure 
vi) If device is in situ, remind the doctor to assess for removal 
The last daily measure was the evaluation of the necessity of an indwelling device and the 
possibility of removal thereof. The purpose for including the measure is the additional risk of 
infection for patients with a device in situ and the increased risk of antimicrobial therapy for an 
extended period of time.   
Other interventions included: 
 Training sessions. 
 Clinical microbiologist provided training on various aspects related to antimicrobial 
stewardship (AMS). The target audience was medical practitioners, pharmacists and 
registered nurses. 
 A clinical pharmacist provided a three-hour session via video conference about antimicrobial 
stewardship to registered nurses. 
 Quality improvement methodology was addressed during a three-hour session by a quality 
specialist  
 IPC training was provided by an IPC specialist and by the IPC practitioner of the hospital. 
 Training was conducted with Powerpoint presentations or via video conferencing.  
 Clinical ward rounds conducted by a clinical microbiologist, treating physicians, IPC 
practitioner and nursing staff were introduced. Patients and their treatment were discussed 
and recommendations were made. 
 The clinical microbiologist was a key role-player in the implementation of the programme. 
Apart from conducting ward rounds, he was also available for telephonic consultations and 
suggested treatment options for individual patients.  
 Prescriptions were monitored for the duration of treatment and where multiple antimicrobials 
had been administered simultaneously for the same patient. 
 Reviewing of the prescription and a stamp on day seven was given by a pharmacist to 
remind the treating medical practitioner to review the necessity of antimicrobial therapy.  
 Daily ward rounds in the CCU were conducted by the IPC practitioner to monitor hand 
hygiene compliance, adherence to IPC principles, environmental cleaning and the 
implementation of appropriate transmission-based precautions. 
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 The use of antimicrobials (excluding antiretroviral therapy and antituberculosis drugs) during 
the pre-and post-intervention periods were evaluated and compared to establish whether 
there had been any change in prescribing practice.   
Data on antimicrobial usage was obtained from the pharmacy data warehouse. Daily antimicrobial 
usage per patient was calculated (begin and end date). The number of antimicrobials that was 
used as well as the duration of treatment was calculated. Both antibacterial and antifungals were 
included. Antiviral therapy and antituberculosis drugs were excluded.  
Antimicrobial usage was measured in defined daily dosages (DDDs). DDDs allows for comparison 
of usage of medication over a period of time and location. It also allows for international 
benchmarking. DDDs are the internationally recognised technical unit of measurement of medicine 
consumption recommended by the WHO (World Health Organisation, 2015b).  
3.6 QUANTITATIVE VARIABLES 
Data was collected using binary, categorical and discrete numerical variables as shown in 
Table 3.1. 
Table 3.1: Type of variable 
Type of variable Data element   
Discrete numerical variable Checklist with daily measures One = Yes Nil = No 
Continuous numerical variable  Age  Number  
Binary variable Knowledge assessment Yes No 
Categorical variable  Resistance patterns of organisms S=Sensitive R=Resistant 
Categorical variable  Gender M=Male F=Female 
 
Percentages of either ‘yes’ or ‘no’ or ‘one’ and ‘nil’ were then calculated with the number of ‘yes’ 
divided by all the documented responses on the checklist to provide a percentage. The same 
methodology was followed for the knowledge assessment. The number of correct answers to 
open-ended questions was added and divided by the total of the particular answer to provide a 
percentage.  
Appropriate specimen collected was presented as a percentage of the total study population and 
the change pre- and post-implementation was calculated.  
Documentation of the antimicrobial included the name and duration of therapy. 
Continuous numerical data was used to record the duration of therapy and the total number of 
antimicrobials. Duration of therapy was defined as a start and end date and the days on therapy 
calculated by adding the days.  The number of antimicrobials administered simultaneously was 
added to provide a total. The type of antimicrobial (name) was documented as a categorical 
variable and the total amount of antimicrobial usage was measured in DDDs.  
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Data was imported onto Microsoft Excel©. Statistical significance of the data was calculated using 
STATA software and Microsoft Excel©.  
3.7 DATA SOURCES/MEASUREMENT 
Data collection was done in a structured way through the utilisation of measuring instruments such 
as questionnaires and checklists. 
Paper-based tools were utilised for the collection of data related to: 
 The knowledge assessment questionnaire; 
 IPC audit; and 
 Daily checklist. 
Data was captured in Microsoft Excel©, analysed and presented in graphs and tables. 
Electronic data sources, namely the patient administration system (AS400) and the IPC electronic 
surveillance programme (ICNet) were utilised to obtain information related to: 
 Patient demographics such as age and gender; 
 Antimicrobials prescribed and duration of treatment; 
 Organisms cultured; and 
 Resistance patterns of organisms.    
Data was exported into Microsoft Excel©, presented in graphs and tables and analysed.  
3.8 DATA COLLECTION INSTRUMENT  
Questionnaires and checklists were utilised to collect data. The purpose of using these instruments 
was to ensure that the objectives are met and that there is correlation between the research 
objectives and problem statement and to furthermore ensure that the same data elements are 
collected continuously in a standardised method.  
The researcher designed the knowledge assessment questionnaire. It was tested on a group of 
registered nurses at the 2013 Critical Care Congress prior to the study and adapted. The 
questionnaire included demographic detail such as age, qualifications, year of completion of study 
and prior IPC and AMS training (Refer to Appendix C for the final knowledge assessment 
questionnaire). 
The majority of the questions were close-ended questions with either a ‘yes’ or ‘no’ answer; ‘true’ 
or ‘false’ or multiple choice.  Although close-ended questions limited the participants to the options 
provided, the purpose of the questionnaire was to test knowledge and therefore no open-ended 
questions were asked. 
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The checklist utilised for the daily monitoring of the AMS interventions was based on the elements 
recommended by the Antibiotic Stewardship Driver Diagram and Change package of the Institute 
for Healthcare Improvement and the Centre for Disease Control and Prevention (2012). The 
researcher developed the checklist and included a section that explains the rationale behind the 
selection of the different elements for clarification.   
This checklist was completed daily by the registered nurse caring for the patient. Compliance to the 
different elements was measured and monitored (Refer to Appendix D for the checklist). 
The researcher originally used a template in Microsoft Excel© to collect data from patient records 
by reviewing each file individually. It was established that all the required data was available from 
electronic data bases and this data was used for the post-intervention assessment.  
3.10 SAMPLE SIZE 
The researcher selected one of the most remote hospitals within the private hospital group to 
conduct the study. The size of the CCU was an important factor to ensure a large enough sample 
size. The unit has twelve beds and in order to compensate for the size of the unit, the study was 
conducted over a longer period (13 months).   
The patients admitted to the CCU represent a portion or sample of the population of the 
community, including the disease and organism profiles of the community.  By including all patients 
admitted or transferred into the unit for longer than 24 hours, in the study, the researcher 
attempted to reduce selection bias and sampling error and to ensure a large enough sample size. 
The records of 407 patients were reviewed pre-and post-intervention and a checklist was 
completed for all patients qualified according to the inclusion criteria. 
3.11 DATA ANALYSIS AND STATISTICAL METHODS 
Data was summarised using tables, graphs and descriptive statistics as appropriate.  Numerical 
data was described as means or medians when it was skewed.  Population estimates have been 
provided by means of 95% confidence intervals. 
Associations between the pre- and post-intervention periods of the study were evaluated.  
Categorical outcomes were compared by means of the Chi-squared test, Fisher exact and the 
unpaired and two-tailed t-test.  Significance level of p= < 0.05 was used. Statistical tests were two-
sided. 
The z-test was used to establish the p-value for two independent proportions.  
Quality improvement methodology and rules for run charts were used to establish whether there 
had been improvement in compliance with the daily measures.  
Calculations were performed using Microsoft Excel©. Demographic and outcomes variables 
compared the pre- and post-implementation period using the t-test. Lengths of stay (LOS) between 
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the admission and discharge dates in the CCU were compared between the pre-and post-
interventions periods using the unpaired t-test. 
Only nurses who had completed both the pre- and post-intervention knowledge assessments were 
included in the data analysis. Only one checklist per patient was included in the data analysis. 
3.12 ETHICAL CONSIDERATIONS 
Ethical clearance for the study was obtained from Stellenbosch University and the ethical 
committee of the hospital group and hospital management in which the study was conducted. 
Informed consent was obtained from the nursing personnel taking part in the knowledge 
assessment. 
Patient information was protected and confidential. Access to information was restricted.  
Information regarding prescription patterns has not been linked to specific patients. All data was 
anonymised. 
3.12.1 Beneficence 
The results of the study do not directly benefit the patients, but the findings of this study will benefit 
patients in future if antimicrobials are used more conservatively and with more consideration, thus 
resulting in lower resistance. The treatment options for severe infections are currently very limited 
and action needs to be taken to prevent the development of further resistance. It means that all 
studies that are investigating interventions to improve prescription habits and reduce resistance will 
benefit the patients.   
3.12.2 Non-maleficence 
Patients did not receive any treatment that was not indicated or that could harm them. No 
treatment was withheld as part of the study. The study did not focus on whether an antimicrobial 
should be given or not; it only monitored the duration of treatment and the amount of antimicrobials 
prescribed.  The study merely prompted prescribing practitioners to carefully consider their 
prescriptions, rather than blindly prescribing out of habit.  
3.12.3 Justice 
Participants had been included in the study in line with the inclusion and exclusion criteria.  
Participants were not discriminated against based on age, race, gender, place of origin or income 
or any other factor not listed in the eligibility criteria.  
3.12.4 Autonomy 
Patients were not researched directly and were not harmed in any way. The data that was 
collected for the study is part of the nursing routine in the critical care unit. It was not “people” who 
were researched, but prescribing practices and the effect of the interventions on antimicrobial 
consumption and subsequently on antimicrobial resistance.  
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3.12.5 Informed consent 
All data was anonymised. A request for waiver of informed consent by patients was approved by 
the Stellenbosch University Ethics committee. Participants working in the unit provided consent. 
(Refer to Appendix A for the consent form and Appendix B for the approval letters from Mediclinic 
and Stellenbosch University.) 
3.12.6 Confidentiality 
All information was regarded as confidential and patient information was anonymised. All Excel 
spreadsheets and data bases were password protected. Only the primary researcher had access 
to the data bases and the statistical analysts and study supervisors had access to the Excel 
spreadsheets.   
3.12.7 Uncovering gross violations  
No gross violations were uncovered during the study. 
3.13 CONCLUSION 
The checklist was completed as part of the critical care nurses’ routine daily record keeping.  In 
addition to the completion of the checklist she had to ensure that the required actions had been 
executed. The findings of the study will benefit the patients and the staff working in the unit. By 
having data that supports statements, practices can be changed to ensure improved outcomes for 
patients.  
The following chapter explores the findings in detail. 
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CHAPTER 4 
RESULTS, DATA ANALYSIS AND INTERPRETATION  
4.1 INTRODUCTION 
This section of the thesis provides an overview of the data that was collected and the analysis and 
interpretation thereof.  
The different interventions and their outcomes are discussed in separate sections of the chapter. 
4.2 DATA ANALYSIS AND STATISTICAL METHODS 
Data was imported into Microsoft Excel© and graphs and tables were compiled. Statistical 
significance of the data was calculated using STATA software and Microsoft Excel©. Refer to 
Section 3.11 for full details of the data analysis and statistical methods of this study. 
4.3 KNOWLEDGE ASSESSMENT 
The same standardised questionnaire was used for the pre- and post-knowledge assessment.  
Questions about basic infection prevention and control (IPC) and antimicrobial stewardship (AMS) 
were asked, under the supervision of the IPC Practitioner of the hospital. The completed 
questionnaires were returned by mail.   
Eighteen staff members (n=18) took part in the pre-intervention knowledge assessment. Seventy 
eight percent (n=14) of the staff were registered nurses and 17% (n=4) were enrolled nurses. One 
participant (6%) had a degree in Nursing. Three of the staff members (17%) had a critical care 
qualification. The median years of experience amongst the staff were 11 years.  Three participants 
(17%) had previous IPC training ranging from an hour-long workshop to one day; only one (6%) 
had a previous one-hour information session on antimicrobial stewardship. 
Twelve staff members took part in the post-training knowledge assessment. The other six were 
either transferred to other nursing units, resigned or were not available on the day of the test. 
Three of the staff with IPC training indicated that they completed the in-house course in 
Fundamentals in IPC.  Only the results from participants who had completed both the pre- and 
post-knowledge assessment were included in the analysis (n=10).  
4.3.1 Elements of standard precautions 
During the pre-assessment, none of the respondents could name even five standard precautions. 
Only two were able to provide four correct answers to the question.  Four participants (40%) had 
three correct answer and four (40%) had two correct answers (Figure 4.1).  
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Figure 4.1: Question 1: Elements of standard precautions 
Although nobody could name five standard precautions in the post-intervention assessment, six 
participants (60%) had four correct answers.  Four participants (40%) had three correct answers.  
4.3.2 Transmission-based precautions 
The second question asked to state the three types of transmission-based precautions. Three 
participants (30%) were able to get full marks for the question. Three participants (30%) provided 
two correct answers and three (30%) had one correct answer. In the pre-intervention group three 
participants (30%) did not had one correct answer compared to one person (10%) in the post-
intervention group (Refer to Figure 4.2).  
 
Figure 4.2: Question 2: Transmission-based precautions 
There was an increase in the number of correct answer in the post-assessment group for question 
two. 
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4.3.3 Routes of transmission of organisms 
The question on the routes of transmission of micro-organisms was poorly answered by the pre-
intervention group and five participants (50%) were unable to name even one correct answer.  One 
respondent (10%) could name one route of transmission, two (20%) had two correct answers. Two 
participants (20%) had three correct answers; none of the respondents could name four routes of 
transmission.  
In the post-assessment six participants (60%) were able to have four correct answers to question 
three and one participant (10%) had all four answers correct (Figure 4.3). 
 
Figure 4.3: Question 3: Routes of transmission of organisms 
4.3.4 Infection vs. Colonisation 
Question 7 tested the understanding of participants of “colonisation” compared to “infection” 
(Figure 4.4). The question asked whether an antimicrobial should be prescribed whenever an 
organism was cultured.  In the pre-assessment none of the participants could answer the question 
correctly.  
 
Figure 4.4: Question 7: Infection vs. Colonisation 
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4.3.5 Medication 
Three participants (30%) knew which antibiotics are a third generation cephalosporin and all 
participants could name at least one carbapenem. All the participants, except one who answered 
“maybe” indicated that they need more training on IPC and AMS.  
4.3.6 Summary 
The Wilcoxon rank sum test was used to compare the pre- and post-intervention knowledge 
assessment. The analysis demonstrated that there was a statistically significant improvement in 
IPC knowledge after training (p=0.002). Baseline IPC knowledge was inadequate prior to the 
intervention.  
4.4 PRE- AND POST-INTERVENTION RECORD REVIEW 
Administrative data from 407 records were reviewed and compared. This included the records of 
190 patients admitted for more than 24 hours in the CCU from 1 October 2013 to 31 May 2014 
prior to the intervention and 217 patients from 1 October 2014 to 1 May 2015.  
4.4.1 Gender and Age distribution  
More males than females were admitted in the CCU during the study. During the pre-intervention 
period 47.4% (n=90) females vs. 52.6% (n=100) males were admitted compared to 43.4% (n=93) 
females and 56.6% (n=124) males during the post-intervention period (Refer to Figure 4.5 and 
Figure 4.6).  
 
Figure 4.5: Gender and Age distribution pre-intervention 
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The ages of the patients remained similar; ranging from 15 to 88 with a mean age of 48 years pre-
intervention and 15 to 86 post-intervention (mean age 50 years).  Having similar age groups in 
both the pre- and post-intervention groups limits confounding factors associated with the different 
risk factors in specific age groups.   
Figure 4.6 demonstrates that the age distribution in both the pre-and post-intervention groups 
remains more or less similar, except for an increase in the age group 45 to 60 years in the post-
intervention group.  
 
Figure 4.6: Gender and Age distribution post-intervention 
The t-test was used to compare the two datasets and no statistically significant difference between 
the two groups was observed.  
4.4.2 Length of stay 
The length of stay (LOS) in CCU varied between two to 81 days with a median LOS of four days 
for the pre-intervention group. The post-intervention group had a LOS of two to 90 days, with a 
median of four days. There were several patients in the post-intervention group with an increase in 
LOS (Refer Figure 4.7). 
Non parametric tests were used to compare the stay in CCU.  
There was no statistically significant difference between the LOS of the two groups. 
LOS in the post-intervention group was longer for individual patients, but the median LOS stayed at 
four days.  
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Figure 4.7: Length of stay in critical care unit 
4.4.3 Antimicrobial therapy 
Three hundred and fifty six (87.5%) of all patients admitted to CCU received an antimicrobial 
during the study period.  Ninety percent (n=171) during the pre-intervention period and 85% (n= 
185) during the post-intervention period (Refer to Figure 4.8).  This is a reduction of 5,3% and is 
not statistical signifiant. 
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Figure 4.8: Percentage of patients admitted to CCU on antimicrobial therapy 
During the pre-intervention period, 36% (n=68) of patients admitted to the CCU were treated with 
more than three antimicrobials and 35% (n=77) during the post-intervention period (Figure 4.9). 
This was not a statistically significant improvement (p=0.515). 
 
Figure 4.9: Percentage of patients on more than three antimicrobials 
Due to limitations in the data collection and data warehouse, it is not possible to know whether the 
antimicrobials were given simultaneously; it merely states that more than three different 
antimicrobials were administered during the stay in CCU.  
Duration of treatment with an antimicrobial ranged from a minimum of one day to a maximum of 
thirty-three days in the pre-intervention group; median six days. The maximum duration of therapy 
with one antimicrobial in the post intervention group was fifty-two days, with a median of six days 
(Refer Figure 4.10).  
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Figure 4.10: Duration of therapy 
The number of patients on antimicrobial therapy for more than 14 days were 12% (n=20) in the 
pre-intervention group and sixteen (9%) in the post-intervention group.  The redution in duration of 
therapy of 26% is not statistically significant (p=0.381). The majority of patients on antimicrobial 
therapy for more than 14 days, were treated with an antifungal agent.  
Sixty-five percent (n=13) in the pre-intervention group and 63% (n=10) in the post-intervention 
group received an antifungal for more than 14 days. This represents a decrease of four percent in 
the duration of treatment in the post-intervention group without a statistically significant recuction.  
The classes of antimicrobials that were most frequently used, were β-lactams, followed by 
carbapenems, quinolones and antifungals (Figure 4.11). No statistically significant difference in the 
use of different classes of antimcirobials was observed between the pre- and post-intervention 
groups., altought there was a slight increase in the user of β-lactams and carbapenems in the post-
intervention group.  β-lactams and carbapenems remained to be used most frequently.  
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Figure 4.11: Classes of most frequently-used antimicrobials 
The most frequently-used antimicrobial was cefuroxime followed by ertapenem and piperacillin in 
both groups and no statistical difference was observed between the pre- and post-intervention 
groups.  
4.4.4 Positive culture before treatment 
Taking an appropriate specimen prior to commencement of therapy is important to ensure that de-
escalation can be practiced and to ensure that the correct antimicrobial is prescribed. 
There was an 8% increase in the number of positive specimens cultured prior or on the day of 
commencement of therapy between the pre- and post-intervention groups (n=38 vs. n=42). 
However, this increase was not statistically significant. 
Although there was a decrease of 44% in the number of patients who commenced an antimicrobial 
before a specimen was taken (Figure 4.12), it was not yet statistically significant (p=0.317). 
Only positive specimens were used in the analysis. Due to ineffeciencies of the IPC surveillance 
system, the number of specimens sent for analysis is not known. Although there is an improvement 
in the number of positive specimens before antimicrobial treatment post-intervention, it is not yet a 
statistically significant improvement in the number of positive specimens prior to the 
commencement of an antimicrobial.  
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Figure 4.12: Specimens taken prior to treatment 
4.5 INTERVENTION 
4.5.1 Checklist with daily measures  
The checklist with specific evidence-based interventions was completed daily. Improvement 
methodology was followed as well as rules for run charts to interpret the results. At least ten 
consecutive data points are required to establish a median and six consecutive data points above 
the median is an indication of a statistically significant improvement.   
4.5.2 Culture before treatment 
A “shift” is clearly observed where six data points are visible above the median (Figure 4.13). This 
indicates a statistically significant improvement in compliance to measuring whether a culture was 
taken prior to commencement of antimicrobial therapy.  There was a 25% improvement in 
compliance since the beginning of the intervention. This improvement is reflected in the previous 
section where the record review also indicated an improvement in positive specimens prior to 
commencement of an antimicrobial.  
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Figure 4.13: Culture before treatment 
4.5.3 De-escalation  
If a culture was not obtained prior to treatment or if there was a negative culture, de-escalation 
cannot be implemented.  Medical practitioners are often hesitant to de-escalate due to a number of 
reasons.   
 
Figure 4.14: De-escalation of therapy 
There was a 53% decrease in compliance to de-escalation as seen in Figure 4.14.  .   
4.5.4 Days on therapy 
Although there are four data points above the median and an increase of 275% in compliance to 
the measuring of “days on therapy”, the improvement was not yet statistically significant.  
(Figure 4.15).  
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Figure 4.15: Duration of therapy 
4.5.5 Number of antimicrobials 
Compliance to monitoring the number of antimicrobials with which a patient had been treated, was 
recorded consistently throughout the study.  Figure 4.16 demonstrates the percentage compliance 
to the daily measure that recorded the number of antimicrobials with which a patient was treated.  
Throughout the study this measure was 100% and the number of antimicrobials was recorded 
daily.  
 
Figure 4.16: Number of antimicrobials 
4.5.6 Assessment of device removal 
The removal of devices was carried out with a median compliance of 66% (Figure 4.17) and a 25% 
increase in compliance since the implementation of the intervention. It was done fairly well since 
commencement of the study. Although there are currently three data points above the median, 
there is not yet a statistically significant improvement in compliance to the measure. 
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Figure 4.17: Assessment of device removal 
4.5.7 Hang time 
Hang time was the final measure that was monitored daily for compliance.  Although there was a 
41% increase in compliance since the beginning of the intervention, no statistically significant 
improvement was observed (Figure 4.18). 
 
Figure 4.18: Hang time 
Although the checklist for compliance was monitored daily, a statistically significant improvement to 
compliance was observed only with the first measure, “culture before treatment”. This is also 
reflected in the data from the record review where an increase in the number of positive specimens 
that were collected prior to commencement of antimicrobial therapy was observed.  
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4.6 INFECTION PREVENTION AND CONTROL AUDIT 
The pre-intervention infection prevention and control (IPC) audit identified some deficiencies that 
needed correction. The inadequacies were highlighted and after training and information sessions, 
a significant improvement were noticed (Figure 4.19). 
Pre
Post
1 RISK 
M ANAGEM ENT
11 / 15
14 / 15
2 INFECTION 
PREVENTION 
AND CONTROL: 
SURVEILLANCE
0 / 14
5 / 14
3 NOTIFICATION 
OF NOTIFIABLE 
CONDITIONS
3 / 7
6 / 7
4 ISOLATION AND 
TRANSM ISSION-
BASED 
PRECAUTIONS
2 / 13
12 / 13
5 IPC WARD 
HYGIENE AUDITS 
0 / 6
5 / 6
6 PERSONNEL 
DEVELOPM ENT 
AND EDUCATION
1 / 4
4 / 4
7 TRAINING
0 / 6
6 / 6
8 POLICIES AND 
PROCEDURES
4 / 6
5 / 6
9 HAND HYGIENE
6 / 11
9 / 11
10 WASTE 
M ANAGEM ENT - 
HEALTHCARE 
RISK WASTE
6 / 6
6 / 6
11 SLUICE
6 / 10
8 / 10
12 HOUSEKEEPING 
8 / 12
11 / 12
121 2 3 4 5 6 7 8 9 10 11
93%
36%
86%
92%
83%
100% 100%
83% 82%
100%
80%
92%
73%
43%
15%
25%
67%
55%
100%
60%
67%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
INFECTION PREVENTION & CONTROL AUDIT
Score per category
Pre Post
 
Figure 4.19: Infection Prevention and Control audit (pre- and post-intervention) 
The Fisher exact test was used to compare the pre- and post-intervention IPC audit. A statistically 
significant improvement in the outcome of the audit was observed (p=0.000).  
4.7 CALCULATION OF ANTIMICROBIAL USE 
Data about antimicrobial usage was obtained from the pharmacy warehouse and was measured in 
defined daily dosages (DDDs).  A decrease in the total use of antimicrobials in the hospital was 
observed, although there was an increase in the use of antifungals (Figure 4.20).  Due to 
limitations in the data warehouse, it was not possible to isolate the data from only the CCU and 
Figure 4.20 demonstrates the antimicrobial use of the hospital, measured in DDDs.  
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Figure 4.20: Defined daily dosages of antimicrobials 
Although there was a decrease in the number of antimicrobials used in the pre- and post-
intervention groups, it was not yet significant.  
4.8 ORGANISM PROFILES 
During the pre-intervention period (1 October 2013 to 31 May 2014) a total of 154 positive 
specimens were cultured.  The majority of the positive cultures were Gram negative organisms of 
which 19% were Klebsiella pneumoniae, followed by Pseudomonas aeruginosa, 
Stenotrophomonas maltophilia and E.coli (Figure 4.21).  During the post-intervention period (1 
October 2014 to 31 May 2015) there was an increase of 32% in the number of positive specimens 
(n=227) cultured compared to the pre-intervention period (n=154).  Klebsiella pneumoniae was 
cultured in 14% of positive specimens collected during the post-intervention group vs. 19% in the 
pre-intervention group. This is a statistically significant reduction of Klebsiella pneumoniae 
(p=0.05). 
Stellenbosch University  https://scholar.sun.ac.za
50 
 
Figure 4.21: Pre-and post-intervention isolates 
The organism profiles in the unit remained more or less similar pre- and post-intervention as 
demonstrated in Table. 4.1.  
Other organisms that were cultured were low in numbers and included the following: 
 Haemophilus influenzae;  
 Proteus mirabilis; 
 Mycobacterium complex and tuberculosis; 
 Enterobacter aerogenes; 
 Candida parapsilosis; 
 Candida dubliniensis; 
 Bacteroides fragilis; 
 Citrobacter freundii; 
 Citrobacter koseri; 
 Klebsiella oxytoca; 
 Methicillin resistant Staphylococcus haemolyticus; 
 Streptococcus viridans;  
 Streptococcus spp. 
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Table 4.1: Organism profiles in the CCU pre- and post-intervention  
Pre-intervention Post-intervention 
Name of organism Number  Percentage 
positive 
Name of organism Number  Percentage 
positive 
Klebsiella pneumoniae 30 19% Klebsiella pneumoniae 31 14% 
Pseudomonas 
aeruginosa 
21 14% Pseudomonas 
aeruginosa 
27 12% 
Stenotrophomonas 
maltophilia 
14 9% Stenotrophomonas 
maltophilia 
20 9% 
Escherichia coli 12 8% Escherichia coli 23 10% 
Staphylococcus 
aureus 
9 6% Staphylococcus 
aureus 
13 6% 
Enterobacter cloacae 8 5.2% Enterobacter cloacae 10 4% 
Candida albicans 7 4.5% Candida albicans 10 4% 
Streptococcus 
pneumoniae 
5 3% Streptococcus 
pneumoniae 
4 2% 
Enterococcus faecalis 5 3% Enterococcus faecalis 7 3% 
Acinetobacter 
baumannii 
5 3% Acinetobacter 
baumannii 
10 4% 
 
Figure 4.22 demonstrates that the organism profiles in the critical care unit remained similar, apart 
from a statistically significant reduction (p=0.05) in Klebsiella pneumoniae.  
The susceptibilities of the most prevalent organisms to frequently-used antimicrobials were 
compared pre- and post-intervention.  
A decrease in susceptibility of Klebsiella pneumoniae is observed against Amoxycillin-Clavulanate, 
Cefuroxime and Piperacillin-Tazobactam. Susceptibility to Ertapenem and Meropenem remained 
similar pre- and post-intervention (Figure 4.22). A decrease in Extended Spectrum β-lactamase 
Producing (ESBL) Klebsiella pneumoniae was however observed. Fourteen out of 29 isolates were 
ESBL producers in the pre-intervention group compared to ten out of 31 in the post-intervention 
group. This reduction was not yet statistically significant (p=0.292).  
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Figure 4.22: Susceptibility of Klebsiella pneumoniae 
There was a decrease in susceptibility of Pseudomonas aeruginosa against both Meropenem and 
Piperacillin-Tazobactam (Figure 4.23), and concerning is the statistically significant decrease in 
sensitivity to Meropenem (p = 0.037). 
 
Figure 4.23: Susceptibility of Pseudomonas aeruginosa 
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Figure 4.24 demonstrates an increase in the susceptibility of E.coli against Amoxycillin-
Clavulanate.  It is however not statistically significant.  
 
Figure 4.24: Susceptibility of Escherichia coli 
Although not statistically significant, a decrease in ESBL producing Klebsiella pneumoniae 
(p=0.292) and E.coli (p=0.464) was observed in the post-intervention group (Figure 4.25). 
The organism profiles in the unit remained more or less similar during the pre- and post-
intervention periods. However, the decrease in the susceptibility of Pseudomonas aeruginosa to 
carbapenems is a major concern, especially in the light of the increase in carbapenem resistance 
worldwide. Nevertheless, the decrease in the ESBL producing Klebsiella pneumonaie and E.coli is 
encouraging.   
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Figure 4.25: ESBL Producers 
4.9 CONCLUSION  
The research methodology and data collection were discussed in detail. Information from various 
data sources was analysed and interpreted. Statistically significant improvements were observed in 
the knowledge of nurses after training, as well as in adherence to infection prevention and control 
(IPC) practices as demonstrated in the IPC audit. These improvements had a positive impact on 
the prevalence of ESBL producing pathogens in the CCU. More positive specimens were noted 
prior to commencement of antimicrobial therapy and there was a decrease in the duration of 
therapy. Nurses played a key role in driving the majority of these improvements.  
The following chapter discusses the findings and offers some recommendations. 
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CHAPTER 5 
DISCUSSION, RECOMMENDATIONS, LIMITATIONS AND CONCLUSION 
5.1 INTRODUCTION 
This chapter is a discussion of the study results; outcomes, recommendations and the 
shortcomings identified. 
5.2 ADDRESSING THE STUDY OBJECTIVES 
The goal of the study was to examine the role of the critical care nurse in the implementation of an 
AMS programme in hospitals in LMICs. The discussion that follows addresses the findings of the 
study in relation to the objectives. 
5.3 DISCUSSION 
5.3.1 Study design and setting 
A pre- and post-interventional study design was the most suitable for the purpose of this research. 
One hospital was utilised for the study to limit possible confounding factors, despite the fact that a 
control group to measure the difference between a group with interventions and one without would 
have been preferred, 
Several interventions were implemented and the impact of these had to be measured and tested. 
The researcher was concerned about the impact of confounding factors such as different disease, 
patient and organism profiles, as well as differences in staff and their interpretation and 
implementation of the proposed interventions on the outcome of the study. An increase in the 
duration of a study of this nature might possibly have more meaningful results if it is performed 
over a longer period as described in the literature (Dortch et al., 2011:15; Yu-Shiuan et al., 
2013:1072).  
5.3.2 Knowledge assessment 
Basic IPC knowledge was inadequate prior to training of the nurses. Knowledge about the routes 
of transmission of organisms and standard precautions was limited. In the pre-assessment a 
limited number of nurses knew the difference between colonisation and infection. This inadequate 
knowledge in itself poses a risk of unnecessary treatment with antimicrobials that contributes to the 
development of AMR.  
However, there was a statistically significant improvement (p=0.0002) in knowledge about IPC and 
AMS of the nurses who took part in the study after training. Improved knowledge could have been 
a contributing factor to the improvement in adherence to IPC principles and the IPC audit results.  
The results demonstrate that IPC training is important and that it positively influences adherence to 
IPC practices (Mehtar et al., 2011:1; Desai, Philpott-Howard, Wade & Casewell, 2000:197-198). 
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5.3.3 Record review pre- and post-intervention 
The patient population remained more or less similar in terms of age and gender pre- and post-
intervention. There was no remarkable difference in the LOS of patients between the two groups. 
Although not statistically significant, a decrease in the number of patients admitted in the CCU 
receiving an antimicrobial in the post-intervention group was observed. Due to limitations in the 
pharmacy billing system, the decrease in the amount of antimicroibals used in the specific unit  
could not be established.  
A 26% reduction in the duration of antimicrobial therapy for more than 14 days was observed in the 
post-intervention group. Although not yet statistically signifiant, nurses played an important role to 
remind the doctor to evaluate the necessity of treatment. There was a significant increase in 
compliance in the daily measure “days on therapy” performed by nurses, utilising a checklist. The 
awareness about the significance of extended therapy created by the visiting clinical microbiologist 
could also have influenced the decrease in duration of treatment.  
Alhough the decrease in the use of antimicrobials might have been causal, the fact that specimens 
were taken prior to the administration of an antimicrobial might have had an influence on the 
decision of the physicians about the necessity for treatment.  
Prescribing habits of treating physicians remained the same and there was no difference in the use 
of different classes of antimicrobials after the implementanion of an AMS programme. Again the 
duration of the study was not long enough to observe a meaningful difference. Of concern was the 
increase in carbapenem resistant Pseudomonas aeruginosa. 
The study did not investigate the indication or appropriateness for antimicrobial therapy, because 
nurses have an insignificant role to play in the decision regarding the necessity of treatment and 
the type of antimicrobial that is prescribed in acute care settings.  
There was a reduction in the amount of patients commencing with treatment before a specimen 
was taken in the post-intervention group. Nurses are responsible for the collection of specimens as 
well as for the administration of antimicrobials and are in a position to ensure that it is being done 
prior to commencement of antimicrobial therapy. It appears that after training, nurses had a better 
understanding of the relevance and importance of collecting an appropriate specimen before 
commencement of treatment.  
Altough nurses might have adequate knowledge about antimicroibals, they are not currently in a 
positition to significantly influence the selection of therapy or duration thereof. They are however in 
a position to remind the physician to evaluate the appropriateness of treatment and question its 
indication. Despite the fact that nurses are already prescribing antimcrobials in the primary 
healthcare setting in South Africa for minor ailments and in the treatment of TB, HIV and the 
syndromic treatment of sexually transmitted diseases, their training and current scope of practice 
does not allow prescribing medication in the complex environment of critically ill patients.   
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Gillespie et al. (2013: 356-366) demonstrated that by providing additional training to nurses, they 
were able to play an important role in the implementation of an AMS programme and a subsequent 
reduction in Staphylococcus areus bloodstream infections.  The role of the nurse is not being 
undermined or diminished, but in the current environment physicians remain the primary precribers 
of medication in acute care settings. Abbo et al. (2012:373) demonstrated that critical care nurses 
had more knowledge about antimicrobials than nurses in other departments and can play a more 
significant role in AMS programmes and the selection of appropriate treatment once they have 
received additional training. 
5.3.4 Intervention with a checklist 
The checklist with specific evidence-based interventions was completed daily, but not always with 
the necessary insight. Additional training was required to ensure that nurses understood the 
significance and importance of completing the checklist and that it was not merely a checklist, but 
that they had to ensure that the measures are executed consistently. Similar methodology had 
been implemented successfully to reduce catheter-associated bloodstream infections (Institute of 
Healthcare Improvement, 2012:2; Pronovost et al., 2006:2725). The researcher believes that 
similar methodology can be utilised to improve other clinical outcomes.  Walker, Reshamwalla and 
Wilson (2012:51-52) proved that a checklist can be utilised to ensure safety in surgery, but that 
additional training and a culture change were required. Similarly, additional training for both nurses 
and medical practitioners, as well as a culture change will be necessary in order to implement AMS 
programmes successfully.  
Knowledge about the causative organism is important to prevent the unnecessary treatment with 
an inappropriate antimicrobial with an increased risk of the development of resistance (Dellit et al., 
2007:168; CDC, 2014:6; IHI & CDC, 2012:6). There was a statistically significant improvement 
in the measure “Culture before treatment” which correlated with an increase in the number of 
positive specimens that were collected prior to commencement of an antimicrobial. A limitation is 
that it is not known how many specimens were collected in total; only the number of positive 
specimens is known. Important to note is the fact that the collection of specimens and the 
administration of an antimicrobial is a nurse-driven intervention. It is evident that if nurses are 
requested to implement an intervention and they understand the rationale behind it, they will 
ensure that it is being done.  
There was no improvement in the de-escalation measure. De-escalation is an important 
intervention to reduce the development of resistance by adapting treatment to a more targeted 
antimicrobial as soon as the result of the microbiological culture is available. (Dellit et al., 
2007:168; Derenski, 2007:179-180; IHI & CDC, 2012:7; Brink et al., 2008: 590). Medical 
practitioners are often hesitant to de-escalate due to a number of reasons. Paruk et al., (2010:614) 
found that only for 23.9% of patients in South African private and public critical care units antibiotic 
treatment had been de-escalated. 
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It is important to note that nurses currently have very little influence on the treatment of patients in 
acute care settings. They can inform the treating physician of the culture result and remind him to 
de-escalate, but it remains the choice of the physician to prescribe another antimicrobial.  
Despite the increase in compliance with the “days on therapy” measure, the improvement was not 
yet statistically significant.  Nurses play an important role in informing physicians about the 
improvement in the condition of the patient and to remind the doctor to evaluate the necessity to 
continue with treatment. Chastre, Wolff, Fagon, Chevret, Thomas, Wemert, Clementi, Gonzalez, 
Jusserand, Asfar, Perrin, Fieux and Aubas (2003:2588) found that there was no significant 
difference in outcome between patients treated for eight versus fifteen days, but that there was an 
increase in resistant pathogens, especially Gram negative pathogens and more infective episodes 
with a longer treatment period.  
The number of antimicrobials administered simultaneously should be limited. Nurses should 
question the necessity of the addition of a new antimicrobial if a previous prescription had not been 
stopped. Although pharmacists are primarily responsible to monitor the number of antimicrobials 
prescribed, nurses administer medication and they play a significant role in monitoring the number 
of antimicrobials that a patient receives during administration of medication, especially if more than 
one prescription chart is utilised. 
Another important aspect that needs monitoring by nurses is the reviewing of the necessity of 
invasive devices.  The significance of the measure is to minimise the risk for the patient of 
acquiring a healthcare-associated infection and subsequent treatment with additional 
antimicrobials or an increase in the duration of treatment if devices are in situ for too long periods 
of time. Devices need to be removed as soon as possible and due to the nature of their work, 
nurses have to suggest removal to physicians based on an improvement in the condition of the 
patient.   
Hang time was the final measure that was monitored daily for compliance. No statistically 
significant improvement was observed, despite a 41% increase in compliance since the beginning 
of the intervention. However, the unit implemented various strategies to improve compliance to the 
measure, such as increasing the ward stock on antimicrobials that are most frequently used to 
reduce the time needed to collect prescriptions at the pharmacy.   
Nurses are primarily responsible for the administration of medication and they need to ensure that 
it is administered as soon as possible after being prescribed by the physician and that the correct 
dose is furthermore administered at the correct time. 
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5.3.5 Infection prevention and control 
An effective infection prevention and control (IPC) programme is one of the most important 
interventions to prevent the spread of resistant pathogens and reduce the impact of antimicrobial 
resistant (AMR) organisms (Royal College of Nursing, 2014:5; Moody et al., 2012:94).  
Nurses are responsible for the implementation and adherence to IPC programmes; including 
surveillance, hand hygiene, environmental cleaning and the implementation and adherence to 
standard and transmission-based precautions (Mendelson et al., 2012:607; Chalfine et al., 2012:1; 
WHO, 2012:68). An important aspect of adherence to IPC principles is the prevention of the 
transmission of resistant pathogens. The IPC audit pre- and post-intervention demonstrated a 
statistically significant improvement in adherence to the IPC programme and IPC principles. A 
statistically significant reduction in the incidence of Klebsiella pneumoniae in the CCU was 
demonstrated. Improved adherence to IPC principles can be a contributing factor to the reduction 
in transmission of pathogens. Although not statistically significant, a reduction in the incidence of 
ESBL producing Klebsiella pneumoniae and E.coli was noted. The improvement in compliance to 
IPC practices is possibly one of the contributing factors for the reduction in ESBL producing 
pathogens.  
Ghafur, Nagvekar, Thilakavathy, Chandra, Gopalakrishnan and Vidyalakshmi (2012:1-2) 
demonstrated similar results with the implementation of a stringent IPC programme; including strict 
adherence to transmission-based precautions, isolation, hand hygiene compliance and monitoring, 
together with an AMS programme.  IPC is essential in all aspects of clinical service delivery and 
nurses have to be recognised as the drivers of the IPC programme and significant members of the 
multidisciplinary team (Royal College of Nursing, 2014:4).  
5.3.6 Training 
In order for AMS programmes to be successful, intensive training programmes for all stakeholders 
are required (Dellit et al., 2007:165; SHEA, IDSA & PIDS, 2012:325). 
Nurses have the potential to play a significant role in the implementation of AMS programmes, but 
need additional training (Gillespie et al., 2013:356-366, National Healthcare System, 2014a:2).  A 
one- or two-day training session is not adequate (Gillespie et al., 2013:356-366). Basic 
microbiology and IPC must be part of an AMS training programme (Pulcini & Gyssens, 2013:199; 
National Healthcare system, 2014b).  
There was a statistically significant improvement in knowledge about IPC and AMS of the nurses 
who took part in the study after training. Improved knowledge could have been a contributing factor 
to the improvement in adherence to IPC principles and the IPC audit results.  This demonstrates 
that IPC training is important and that it has a positive impact on outcomes. Different methods 
should be used for training. The result of the knowledge assessment post intervention indicated 
that nurses require more training on AMS.  
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E-learning modules are valuable, due to the interactive nature thereof (Nathwani et al., 2011:22). 
However, availability and access to computers can potentially be a limitation in an e-learning 
approach. Not all healthcare workers have access to computers after hours and there is not 
necessarily adequate time to spend on studies during working hours.  Video conferencing and 
applications used for communication, such as Webex and Lync communicator, are valuable tools 
in providing interactive learning sessions at remote locations without the need to travel (Kellie, 
2011:1181-1183).  
Educating nurses without educating pharmacists and doctors will not have the desired impact.  The 
complete multi-disciplinary team needs training in order to have successful antimicrobial 
stewardship programmes (Sahoo et al., 2010:636).  Clinical pharmacists and microbiologists can 
assist with training in areas where infectious diseases specialists are not available (Budwall, 
2010:116). 
It is however important to note that improved knowledge alone is not enough for the 
implementation of any programme; a change in behaviour of all stakeholders is necessary in order 
to achieve sustainable improvement. Training programmes should incorporate quality 
improvement, change management and behavioural change (Dellit et al., 2007: 165, Moongtui 
et al., 2011:107, National Healthcare System, 2014b). 
5.3.7 The role of the clinical microbiologist 
The role of the clinical microbiologist in LMICs is indispensable, especially in the absence of 
infectious diseases specialists. The clinical microbiologist plays a significant role in communicating 
results to the treating physicians and recommending treatment plans. Clinical microbiologists can 
conduct ward rounds and provide training on antimicrobial usage and AMS to both doctors and 
nurses. Goff (2011:17) and Lowman (2015:359-360) stated that clinical microbiologists have an 
important role to play in compilation of unit-specific antibiograms with organism and resistant 
profiles.  In this study, a clinical microbiologist played a key role in the implementation of the AMS 
programme in the hospital. He provided training, support and recommended treatment options and 
advised the critical care nurses on practices related to IPC.  
5.3.8 The role of the critical care nurse  
Nurses played a prominent role in the study. Although other role-players were involved, the study 
focused on the role of the nurse as a member of the multidisciplinary AMS team.  As reported by 
various authors, nurses are the primary caregivers and the advocates of the patient (Edwards, 
Drumright et al., 2011:4; Crombie, 2012:16; Royal College of Nursing, 2014:6).  They are 
furthermore responsible for the collection of specimens, administration of medication and 
monitoring of side effects (Gillespie et al., 2013:356; Budwall, 2010:116; Moongtui et al., 
2011:2014).  Despite the fact that nurses are not responsible for making decisions regarding the 
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type of antimicrobial that is prescribed, duration of therapy and de-escalating treatment, they can 
implement certain aspects of an AMS programme and adhere to the principles of the programme.  
Nurses completing a checklist with specific evidence-based measures on a daily basis can assist 
with the implementation of and compliance to an AMS programme (Perla et al., 2011:46; Pulcini 
et al., 2008:1384-1388). It has been demonstrated in this study that the use of a checklist can lead 
to an improvement in compliance to certain evidence-based measures. It is however important that 
the measures can be influenced and driven by nurses.  
Nurses were responsible for the implementation of the intervention, more specifically the utilisation 
of a checklist to ensure that different evidence-based measures were implemented and adhered to.   
In the study, nurses ensured that specimens were collected on admission of patients to the CCU 
where indicated and prior to commencement of therapy. This is demonstrated in the increase in the 
number of positive specimens that were cultured prior to treatment as well as in the “culture before 
treatment” measure with a statistically significant improvement in compliance (Perla et al., 2011:47; 
CDC, 2014:6).  
Traditionally, nurses will wait for the instruction from the treating physician to obtain a specimen. 
Valuable time will be lost and treatment might commence without an appropriate specimen. 
Through training, nurses working in the CCU understood the importance of appropriate and 
timeous specimen collection. Nurses can play a key role to ensure that specimens are only taken 
when clinically indicated, that they are taken correctly and of good quality, that the specimens 
reach the laboratory within the shortest possible time and that they are stored and transported 
correctly to ensure accurate analysis (Royal College of Nursing, 2014:6). Furthermore, if nurses 
have the mandate to collect specimens when required, they will ensure that it is done.  
Additional training ensured that nurses involved in the study understood the importance of hang 
time and implemented several measures to ensure that antimicrobials are administered promptly to 
critically ill patients to reduce mortality (Gaieski, Pines, Band, Mikkelen & Massone et al., 2010:1; 
Dellinger, Levy, Rhodes, Annane, Gerlach, et al., 2013:171; Dellit et al., 2007: 168; Surviving 
Sepsis Campaign, 2012:591). One of the most important interventions was to have frequently-used 
antimicrobials available in the unit to reduce the time of collecting prescriptions at the pharmacy. 
Nurses can play a significant role in monitoring the duration of antimicrobial therapy by monitoring 
the clinical condition of the patient and reminding the treating physician on a daily basis to review 
the necessity of treatment (Ladenheim et al., 2013:48; CDC, 2014:6). In this study, nurses played 
an important role to remind the treating physician to evaluate the duration of treatment. Although a 
statistically significant decrease in the duration of therapy was not recorded in the study, a 
decrease in the number of patients treated with an antimicrobial for more than 14 days was 
observed. Because nurses are responsible for the administration of antimicrobials, are familiar with 
the clinical condition of the patient and conducting ward rounds with the treating physician, they are 
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in an ideal position to remind the doctor of the duration of therapy and suggest that the treatment 
should be re-evaluated (Gillespie et al., 2013:356; Budwall, 2010:116; Moongtui et al., 2011:2014).  
Nurses furthermore need to ensure that the prescription charts are completed correctly with the 
dose and duration of therapy and ensure that allergies are recorded. Nurses are also responsible 
for the education of the patient and family (Royal College of Nursing, 2014:7). It is important to 
note that it is not the responsibility of nurses to prescribe antimicrobials in acute care settings, but 
merely to remind the physician to evaluate the necessity of treatment (Gillespie et al., 2013:365). 
Nurses can also utilise their knowledge about improvement methodology to ensure compliance to 
these measures and to test changes prior to implementation to ensure improvement and 
sustainability (Perla et al., 2011:46; Institute of Healthcare Improvement, 2015). 
Nurses might not be in a position to directly influence the physician to change treatment (Charani 
et al., 2013: 189-194), but they are significant role-players in the implementation of an AMS 
programme. Their key responsibilities must be to ensure that appropriate cultures are taken prior to 
treatment; that results are communicated to the treating physician; that antimicrobials are 
administered in the correct dose at the correct time and for the correct duration; and that it is 
documented (Edwards, Drumright et al., 2011:6; Abbo et al., 2012:376; Royal College of Nursing, 
2014:6-7; Ladenheim et al., 2013:48; CDC, 2014:6). 
Nurses play a key role in the implementation and adherence to an IPC programme with a 
subsequent reduction in the transmission of pathogens. This study demonstrated that improvement 
in adherence to IPC principles can have an impact on the prevalence of pathogens in a nursing 
unit. Key aspects of an IPC programme that nurses are responsible for, are improved surveillance, 
compliance to hand hygiene, standard and transmission-based precautions, and environmental 
cleaning (Royal College of Nursing,  2014:6-7; CDC, 2014:6; Chalfine et al., 2012:1; Mendelson 
et al., 2012:607; WHO, 2015a:5). 
Nurses are playing a significant role in the implementation of an AMS programme, but their role is 
not recognised and acknowledged. Without the contribution and cooperation of nurses, it will not 
be possible to implement an AMS programme.  
5.4 FUTURE RESEARCH 
Recommendations for future research are to evaluate the impact of an antimicrobial stewardship 
programme where nurses play a key role.  Such research will have to be conducted over a longer 
period to evaluate the impact thereof. 
Evaluating the impact of adding an infectious diseases specialist to an antimicrobial stewardship 
team where nurses play a more prominent role should also be considered as well as whether the 
utilisation of a dedicated antimicrobial prescription chart can change prescribing patterns 
sustainably. Comparing outcomes with a control group might have more significant findings. 
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5.5 LIMITATIONS 
The distance to the hospital where the study was conducted was a limiting factor which made 
follow-up challenging.  The duration of the study (thirteen months) and absence of a control group 
were additional limitations. Studies evaluating the effect of the implemenatation of an AMS 
programme need to be evaulated over a longer period.  
5.6 BIAS 
Due to the fact that exposure was not measured between two different groups, the possibility of 
bias is limited.  
Confounding factors in the study might be an inadequate infection prevention and control 
programme. Measuring healthcare-associated infections (HAI) is not an outcome measure in the 
study. The acquisition of a HAI will therefore not have a direct influence on the results, but it might 
have an influence on the duration of treatment and the amount of antimicrobials prescribed if 
patients acquire a HAI during their stay in hospital. The length of stay in CCU is a contributing 
factor to the acquisition of HAIs. 
Outbreaks of specific pathogens might have an influence, due to the fact that patients might 
require more antimicrobials for a longer duration. No outbreak was however notified during the 
study period. 
The same time of the year was used for the pre-and post-data analysis to reduce confounding 
factors related to seasonal variations such as influenza. 
Many interventions focusing on the role of the nurse in the implementation of an AMS programme 
had been implemented simultaneously. It is therefore problematic to say which one of the 
interventions was the most successful. It is important to note that with the implementation of an 
AMS programme several interventions need to be implemented together to have the desired 
outcome.  
5.7 HYPOTHESIS 
The null hypothesis had been rejected and the study demonstrated that critical care nurses can 
play an important role in the implementation of an antimicrobial stewardship programme. Although 
the statistical significance was limited, changes in practices were observed.  
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5.8 CONCLUSION  
In many countries, nurses are responsible for the implementation of IPC programmes and for 
strategies to reduce healthcare-associated infections; including quality improvement projects 
(Royal College of Nursing, 2014:5).  
Nurses have to be included in AMS programmes to successfully implement these programmes. 
They play a significant role in the implementation and execution of interventions and can ensure 
that these programmes are sustainable. The role of the nurse should be directed at nursing tasks 
related to the administration of medication, monitoring of the clinical condition of the patient, 
communication with the physician and implementation and adherence to IPC programmes. The 
role of the nurse in the AMS team should not be underestimated. With the necessary training on 
the use of antimicrobials, IPC and quality improvement, nurses will be able to play an important 
role in the implementation of an AMS programme.    
The role of critical care nurses in the implementation of an AMS programme should be recognised 
and acknowledged by the multidisciplinary team.  
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APPENDIX A: 
PARTICIPANT INFORMATION LEAFLET AND CONSENT FORM 
 
TITLE OF THE RESEARCH PROJECT: 
The role of the critical care nurse in the successful implementation of an antimicrobial stewardship 
program in a resource-limited country. 
REFERENCE NUMBER: 
 S13/10/226 
PRINCIPAL INVESTIGATOR:  
Briёtte du Toit 
ADDRESS: 
Mediclinic Pty Ltd 
Tijgerpark 1 
Willie van Schoor Avenue 
Bellville 
7530 
CONTACT NUMBER:  
Mobile: 072 463 4444 
Office: 021- 9436016 
 
You are being invited to take part in a research project.  Please take some time to read the 
information presented here, which will explain the details of this project.  Please ask the principal 
investigator any questions about any part of this project that you do not fully understand.  Your 
participation is voluntary. It is very important that you are fully satisfied that you clearly understand 
what this research entails and how you could be involved.   
This study has been approved by the Health Research Ethics Committee at Stellenbosch 
University and will be conducted according to the ethical guidelines and principles of the 
international Declaration of Helsinki, South African Guidelines for Good Clinical Practice 
and the Medical Research Council (MRC) Ethical Guidelines for Research. 
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WHAT IS THIS RESEARCH STUDY ALL ABOUT? 
 The study will only be conducted at Mediclinic Limpopo.  
 The aim of the study is to examine the role of critical care nurses as significant role players 
in the implementation of an antimicrobial stewardship program in a hospital of a resource-
limited country. Antimicrobial resistance is a problem worldwide and also in South Africa. 
We do not have the necessary resources such as clinical pharmacists and infectious 
disease specialists for the implementation of an antimicrobial stewardship program as 
described in various studies conducted in countries with adequate resources. Resource-
limited countries therefore have to look for alternative resources to assist with the 
implementation of the program.  
 An audit of the prescription charts will be conducted retrospectively to establish a baseline 
of prescribing practices.  
o Critical care nurses will then be trained on infection prevention and control, as well 
as on antimicrobial stewardship.  
o CPD lectures will be presented to the medical practitioners.  
o Daily audits of prescriptions charts will be conducted of patients in ICU utilising a 
checklist.  
o After the implementation period a post intervention audit will be conducted again to 
establish whether the intervention had the desired effect.  
 There will not be any randomised process. All patients in ICU will be included, except for 
patients that is in the unit for post-operative monitoring.  
WHY HAVE YOU BEEN INVITED TO PARTICIPATE? 
 The researcher needs to include all medical practitioners admitting patients in the critical 
care unit and critical care nurses in the study to establish whether the implementation of 
certain interventions changes prescribing habits.  
WHAT WILL YOUR RESPONSIBILITIES BE? 
 The critical care nurses will have to do the daily audits in the critical care units, utilising a 
checklist.  
 It will also be required of the critical care nurse to remind the doctor to review the 
prescription after 5 days. 
 The study wants to proof that critical care nurses can be a significant role player in the 
implementation of an antimicrobial stewardship program.  
 CPD lectures on antimicrobial utilisation will be presented to the medical practitioners.  
 The study wants to proof that an increase in knowledge of antimicrobial stewardship will 
change prescribing habits. (It is currently an assumption that the prescribing habits of 
medical practitioners need to change.) 
WILL YOU BENEFIT FROM TAKING PART IN THIS RESEARCH? 
 The benefit of taking part in the study will be that the knowledge of the individual might 
improve. 
 Patient outcomes might improve 
 Antimicrobial resistance will reduce. The reduction of antimicrobial resistance is however a 
long term goal.  
 The consumption of antimicrobials will be reduced. 
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ARE THERE ANY RISKS INVOLVED IN YOUR TAKING PART IN THIS RESEARCH? 
 There are no risks in taking part in the study. 
WHO WILL HAVE ACCESS TO THE MEDICAL RECORDS? 
 The information collected will be treated as confidential and protected.  The identity of the 
participants will remain anonymous.  It will only by the researcher and the statistical analyst 
who will have access to the information and the data will be anonymized.  
WILL YOU BE PAID TO TAKE PART IN THIS STUDY AND ARE THERE ANY COSTS 
INVOLVED? 
 No you will not be paid to take part in the study.  It will be part of your daily tasks. There will 
be no costs involved for you, if you do take part. 
IS THERE ANY THING ELSE THAT YOU SHOULD KNOW OR DO? 
 You can contact Ms Briёtte du Toit at tel. 072 463 44444 if you have any further queries or 
encounter any problems. 
 You can contact the Health Research Ethics Committee at 021-938 9207 if you have any 
concerns or complaints that have not been adequately addressed by your study doctor. 
 You will receive a copy of this information and consent form for your own records. 
 
DECLARATION BY PARTICIPANT 
By signing below, I …………………………………..…………. agree to take part in a research study 
entitled: The role of the critical care nurse in the successful implementation of an antimicrobial 
stewardship program in a resource-limited country. 
I declare that: 
 
 I have read this information and consent form and it is written in a language with which 
I am fluent and comfortable. 
 I have had a chance to ask questions and all my questions have been adequately 
answered. 
 I understand that taking part in this study is voluntary and I have not been pressurised 
to take part. 
 I may choose to leave the study at any time and will not be penalised or prejudiced in 
any way. 
 
Signed at (place) ......................…........…………….. on (date) …………....……….. 2014. 
 ...................................................................  ................................................................. 
Signature of participant Signature of witness 
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DECLARATION BY INVESTIGATOR 
I (name) ……………………………………………..……… declare that: 
 
 I explained the information in this document to ………………………………….. 
 I encouraged him/her to ask questions and took adequate time to answer them. 
 I am satisfied that he/she adequately understands all aspects of the research, as 
discussed above 
 I did/did not use an interpreter.  (If an interpreter is used then the interpreter must sign 
the declaration below. 
 
Signed at (place) ......................…........…………….. on (date) …………....……….. 2014. 
 ...................................................................  ................................................................. 
Signature of investigator Signature of witness 
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APPENDIX B: 
LETTERS OF CONSENT FROM MEDICLINIC AND STELLENBOSCH 
UNIVERSITY 
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APPENDIX C:  
KNOWLEDGE ASSESSMENT QUESTIONNAIRE 
Hospital: 
Nursing unit: 
Date of completion: 
Permanent or Agency staff: (Please circle) 
Knowledge Assessment Critical Care Nurse 
1 Age in years 
  Date of birth 
  Age 
2 Qualification 
  Registered nurse 
  Enrolled nurse/Staff nurse 
  Bachelors in Nursing 
  Nursing Diploma 
  Post-graduate Diploma: Specify 
  Critical Care Nursing Qualification 
  Other: Specify 
3 In which year did you qualify?  
  Year: 
4 Do you have any Infection Prevention and Control (IPC) Training? 
  Yes 
  No 
  Unsure 
5 What was the duration of the training (Please specify number of days, weeks, months, years) 
    
6 Where did you receive the IPC training? 
  Mediclinic 
  University of Stellenbosch  
  University of Witwatersrand  
  Other (Please specify): 
7 Did you have any training on antimicrobial stewardship? 
  Yes 
  No 
  Unsure 
8 If yes, when? (Specify the date (year) of the training) 
    
9 Duration of the training (Please specify number of days, weeks, months, years) 
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  QUESTIONS 
10 List 5 elements of Standard Precautions. (5) 
10.1   
10.2   
10.3   
10.4   
10.5   
11 List the 3 types of Transmission-based Precautions. (3) 
11.1   
11.2   
11.3   
12 Name 4 ways in which micro-organisms can be transmitted. (4) 
12.1   
12.2   
12.3   
12.4   
13 Alcohol is a good disinfectant for surfaces and hands. (1) 
  TRUE 
  FALSE 
14 Surfaces must be cleaned before it can be disinfected. (1) 
  TRUE 
  FALSE 
15 Is it important to take a culture before an antimicrobial is prescribed? (1) 
  Yes 
  No 
  Not always indicated 
  Please motivate your answer.  
16 A patient should always be treated with an antimicrobial when an organism is cultured? (1) 
  Yes 
  No 
  It depends on clinical signs and symptoms of infection. 
17 Name two carbapenems (1) 
    
    
18 Which of the following antimicrobials is a third generation cephalosporin?(1) 
  Cefepime 
  Meropenem 
  Gentamycin 
  Ceftriaxone (Rocephin) 
  Kefzol 
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  QUESTIONS 
19 Is the statement true or false: The inappropriate use and over-use of antimicrobials contribute to 
the development of resistance amongst micro-organisms. (1) 
  TRUE 
  FALSE 
20 The treatment of an infection depends on the sensitivity of the organism that was cultured. (1)  
  Yes 
  No 
  The sensitivity is not an important aspect to consider. The type of organism that was cultured is 
more important than the sensitivity.  
21 I would like to have more knowledge about IPC 
  Yes 
  No 
  Unsure 
22 I would like to have more knowledge about antimicrobial usage 
  Yes 
  No 
  Unsure 
 Total: 20 
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APPENDIX D:  
CHECKLIST WITH DAILY MEASURES 
Yes No N/A Yes No N/A Yes No N/A Yes No N/A Yes No N/A Yes No N/A Yes No N/A Yes No N/A Yes No N/A Yes No N/A
1 Culture before antimicrobial 
therapy (Only mark once 
on initiation of treatment)
2 Hang Time (Only mark 
once on initiation of 
treatment)
3 De-escalation
4 Duration of therapy (Mark 
daily: day 1/2/3/4)
Duration of therapy (Mark 
daily: day 1/2/3/4)
5 Number of antimicrobials (on 
any given day)
6 If device is in situ, assess 
for removal
7 Comments:
Definitions
Duration of therapy
Number of antibiotics 
Prolonged treatment w ith an antibiotic drive restance and increase collaterial damage (e.g. The risk to develop C.diff etc.)
Seven (7) days is appropriate to treat most infections in immuno compotent patients. [MARK THE DAYS (1,2,3,4, etc)]
To administer a targeted antibioticthat the organism is sensitive to once an organism w as cultured. 
Empiric antibiotic: 
The initiation of treatment prior to the determination of a confirmed diagnosis and before an organism w as cultured.
Culture before treatment
Hang Time
Mediclinic Limpopo
Implementation of Antimicrobial Stewardship (AMS) in ICU
Stewardship measures Checklist 
Day 6 Day 7 Day 8 Day 9 Day 10
Activity Date
Day Day 1 Day 2 Day 3 Day 4 Day 5
Note the number of antibiotics on any given day
The time interval betw een presribing of an antimicrobial and administration to the patient. (Duration in minutes or hours) (MARK ONLY ONCE)
It is important to know  w hat organism w as cultured and to w hat antibiotics it is sensitive. ( MARK ONLY ONCE)
One dose of antibiotic can influence the susceptibility report.
De-escalation:
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APPENDIX E:  
INFECTION PREVENTION AND CONTROL AUDIT 
  MEDICLINIC INFECTION PREVENTION &  CONTROL AUDIT 
  Infection Prevention and Control (IPC)       
  Hospital:     
  
  
  Date:     
  Surveyor:     
  Criteria 
C
o
m
p
li
a
n
t 
N
o
n
-
C
o
m
p
li
a
n
t Comments / 
Recommendations 
  
1 RISK MANAGEMENT 1 0   
1.1 Clinical Risk Manager (CRM) trained in IPC       
1.2 Training was at least 6 months (provide details of 
IPC course) 
      
1.3 Dedicated assistant or successor       
1.4 Successor is trained in IPC (provide details)       
1.5 Work profile available for the CRM and assistant       
1.6 Competency Model available for the CRM and 
assistant 
      
1.7 5 Biggest IPC risks are identified (provide details)       
1.8 Quality improvement processes in place to improve 
outcomes (provide details) 
      
1.9 Best care always (BCA) implemented       
1.10 Catheter-associated urinary tract infection (CAUTI) 
Bundle 
      
1.11 Central line-associated bloodstream infection 
(CLABSI) Bundle 
      
1.12 Ventilator-associated pneumonia (VAP) Bundle       
1.13 Surgical site infection (SSI) Bundle       
1.14 Reduction in healthcare-associated infection (HAI) 
rates (provide details) 
      
1.15 Proof that action plans are implemented to improve 
rates 
      
        Total score: 15 
2 INFECTION PREVENTION AND CONTROL: 
SURVEILLANCE 
1 0   
2.1 ICNet accessed daily       
2.2 Number of open cases       
2.3 Admission/Discharge/Transfers (ADT) are 
complete 
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2.4 Cases discharged and not only closed       
2.5 Isolation periods recorded       
2.6 HAI classification done for all organisms       
2.7 HAI classification done correctly       
2.8 Conditions recorded       
2.9 Notes imported       
2.10 CRM (and assistant)  knows healthcare-associated 
infection (HAI) rates 
      
2.11 Evidence that HAIs are investigated       
2.12 CRM (and assistant) knows organism profiles of 
the hospital 
      
2.13 CRM knows which patients are in isolation and for 
what reason (organism cultured) 
      
2.14 Proof of daily visits to high-risk units and to follow 
patients up 
      
        Total score: 14 
3 NOTIFICATION OF NOTIFIABLE MEDICAL 
CONDITIONS 
1 0   
3.1 GW17/5 notification book is available       
3.2 The name and contact details of the CDC at the 
Department of Health (DoH) is available 
      
3.3 Proof of the weekly reports to the DoH       
3.4 Proof that Notifiable Medical Conditions are notified 
to the DoH 
      
3.5 There is a list of notifiable conditions in all 
departments 
      
3.6 Staff is familiar with the Corporate Policy 
(Notifications of Notifiable Medical Conditions) 
      
3.7 Staff knows the procedure related to priority A 
Notifiable Medical Conditions 
      
        Total score: 7 
4 ISOLATION AND TRANSMISSION-BASED 
PRECAUTIONS 
1 0   
4.1 The corporate policy "Isolation" is available and 
staff is familiar with its content 
      
4.2 Patients with multi-drug resistant organisms 
(MDROs) are isolated as far as possible 
      
4.3 Patients with diseases transmitted via the airborne 
route (measles, TB, chickenpox) can be isolated in 
a negative pressure ventilation room or 
alternatively can be isolated to prevent 
transmission to other patients 
      
4.4 N95 respirators are available and a fit test has 
been done on all staff members (Proof of training) 
      
4.5 Correct transmission-based precautions are 
implemented (Observed) 
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4.6 There is proof that compliance to transmission-
based precautions are monitored 
      
4.7 Appropriate Personal Protective Equipment (PPE) 
is worn 
      
4.8 Isolation poster is displayed and it is a reflection of 
the type of precautions that are implemented 
      
4.9 PPE is stored correctly       
4.10 Documentation is stored outside the room       
4.11 An area has been dedicated to accommodate a 
patient with a Viral Haemorrhagic fever 
      
4.12 There is documented evidence that staff members 
were trained on the donning and doffing of PPE 
      
        Total score: 12 
5 IPC WARD HYGIENE AUDITS        
5.1 Proof that monthly hygiene audits are conducted       
5.2 Proof that non-compliance is addressed and action 
plan is available for corrective actions 
      
5.3 Environmental cleaning is monitored (Proof: 
Checklist) 
      
5.4 Temperature of fridges are monitored daily and 
recorded 
      
5.5 Only approved multidose vials are used (e.g. 
Insulin) 
      
5.6 All multidose vials have a date when it was first 
opened 
      
        Total score: 6 
6 PERSONNEL DEVELOPMENT AND EDUCATION       
6.1 A succession strategy is available for Clinical Risk 
Manager (CRM) 
      
6.2 There is a person trained in IPC who can stand in 
for the CRM 
      
6.3 There is proof that the CRM/IPC assistant attended 
training sessions to further their knowledge 
      
6.4 CRM/IPS assistant belongs to IPC societies and 
regularly receive updates on new studies (e.g. IPC 
today, CDC updates, etc.) 
      
        Total score: 4 
7 TRAINING       
7.1 IPC is presented as part of the induction of new 
personnel (on-boarding) 
      
7.2 IPC training is included is the annual training 
programme 
      
7.3 Proof of training sessions are available in the 
nursing units and for the hospital 
      
7.4 Proof on situational (on the spot) training (training 
records available) 
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7.5 There are staff members who have completed the 
IPC course (number per year) 
      
7.6 The CRM/IPC assistant is involved in the IPC 
training of personnel 
      
        Total score: 6 
8 POLICIES AND PROCEDURES       
8.1 CRM knows the content of the IPC policies       
8.2 Infection prevention and control policies are 
available to all personnel 
      
8.3 Personnel knows the content of the IPC policies       
8.4 Personnel knows where to access the IPC policies       
8.5 Personnel knows where to find policies that are only 
available electronically, and can access the 
Intranet/shared folder 
      
8.6 There is documented proof that personnel reads the 
policies 
      
     Total score: 6 
9 HAND HYGIENE       
9.1 Alcohol hand rub is available and accessible at the 
point of care 
      
9.2 Alcohol hand dispensers are working and provide 
an efficient amount of solution (2-3 ml, i.e. enough 
to rub hands for at least 15-30 seconds) 
      
9.3 Paper towels and liquid soap are available at the 
basins 
      
9.4 Elbow-operated taps are available       
9.5 Pedal bins are available for discarding of used 
paper towels 
      
9.6 Hand hygiene compliance is measured on an 
ongoing basis 
      
9.7 Hand hygiene compliance rates are available       
9.8 There is evidence that hand hygiene is regularly 
addressed  
      
9.9 Hand hygiene posters are available and visible       
9.10 Staff is familiar with the 5 moments of hand hygiene 
(Ask staff) 
      
9.11 Gloves are used appropriately       
        Total score: 11 
10 WASTE MANAGEMENT - HEALTHCARE RISK 
WASTE 
      
10.1 Correct packaging/labelling of waste       
10.2 Waste containers in nursing units are marked        
10.3 Method to dispose of empty glass vials (Name of 
recycler) 
      
10.4 Sharp containers are secured and available at the 
point of generation 
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10.5 Filling line is marked (3/4) on the sharp containers       
10.6 Dedicated area for the storage of full sharp 
containers 
      
        Total score: 6 
11 SLUICE       
11.1 Bedpan washer available that washes on a hot 
cycle 
      
11.2 If bedpan washer is not available, are bedpans 
disinfected: Explain 
      
11.3 No laundry are sluiced        
11.4 No instruments are cleaned in sluice       
11.5 Bedpans are stored inverted       
11.6 No objects are stored on the shelf underneath 
bedpans 
      
11.7 Patient wash basins are stored dry and inverted       
11.8 Patient wash basins are cleaned and disinfected 
after use 
      
11.9 Hand wash basin is available in sluice       
        Total score: 9 
12 HOUSEKEEPING        
12.1 There is a contract and service level agreement 
with the cleaning company 
      
12.2 Evidence of pre-employment examinations 
available 
      
12.3 Evidence that housekeeping staff received Hep B 
vaccinations 
      
12.4 Evidence that housekeeping staff received IPC 
training 
      
12.5 IPC training programme available       
12.6 Cleaning policies and procedures available       
12.7 Staff knows the content of the policies and 
procedures 
      
12.8 Staff is familiar with the different disinfectants and 
its uses 
      
12.9 Staff is familiar with the colour coding system of 
cleaning 
      
12.10 There is dedicated trolleys for the cleaning of 
isolation rooms 
      
12.11 Cleaning staff members wear protective clothing 
during the cleaning procedure 
      
12.12 Cleaning staff members are familiar with the 
Isolation policy 
      
        Total score: 12 
        Total score: 108 
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